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ABSTRACT 
The sub-therapeutic use of antibiotics for growth promotion in food animal production, 
has engendered substantial debate on the dissemination of antibiotic resistance via the 
food chain, specifically, the probability of antibiotic use in food production creating a 
reservoir of resistant bacteria and/or resistance genes that may spread to humans 
thereby limiting the therapeutic value of antimicrobial drugs. In the absence of any 
surveillance programme on food-borne bacteria in South Africa, this study focussed on 
Campylobacter spp. in poultry and encompassed a literature review on the prevailing 
debate on the dissemination of antibiotic resistance via the food chain, a phenotypic 
observational study on the prevalence and antibiotic resistance profiles of 
Campylobacter spp. isolated within and across different poultry farming systems and a 
genotypic component that covered identification methods, plasmid profile 
determination and strain typing. 
Identification methods for Campylobacter spp., viz, biochemical tests and matrix 
assisted laser desorption ionization- time of flight (MALDI-TOF) mass spectrometry 
was compared to the PCR which is considered the gold standard as a molecular method 
of identification. The MALDI-TOF was shown to be superior to the biochemical tests 
for the identification of C. coli but equivalent to the biochemical tests for C. jejuni. Of 
the 363 samples collected in total, the frequency of thermophilic Campylobacter was 68 
% in rural farms (or informally reared poultry), 47 % in both commercial free-range 
and industrial broilers and the highest in industrial layers at 94 %. Antibiotic resistance 
analysis showed that isolates from the rural farming systems were significantly (P < 
0.01) more susceptible to ciprofloxacin, tetracycline and erythromycin when compared 
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to the other farming systems. Significant (P < 0.001) antibiotic resistance differences 
were detected between broilers (5 - 8 week lifespan), and layers (36 - 52 week lifespan) 
for gentamicin, ciprofioxacin and tetracycline. 
Plasmids were fonnd be harboured by isolates in all the farming systems; in 84 % of 
isolates from free-range broilers, 77 % of isolates from industrial broilers, 83 % of 
isolates from industrial layer hens and 75 % of isolates from the rural farming system. 
The PFGE genotyping of 42 Campylobacter isolates generated 39 Sma! types. 
Substantial and substantive genetic diversity was observed between and within farming 
systems. The lack of correlations amongst the parameters within and between farming 
systems attested to the diversity and complexity of phenotypes and genotypes and 
indicated de novo evolution in response to antibiotic selection pressure and animal 
husbandry practices. 
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Antibiotic drugs can be used in food animals both therapeutically (to treat a disease) and 
sub-therapeutically. The latter usually occurs over long periods in smaller quantities to 
improve the animal's growth rate and feed conversion efficiency, this practice being 
referred to as growth promotion. The possible mechanisms for growth promotion appear to 
include enhancement of vitamin production by gastrointestinal microorganisms, 
elimination of subclinical populations of pathogenic organisms, and increased intestinal 
absorption of nutrients (Bilgili, 2005; Chopra and Roberts, 2001). Theoretically, it is 
possible for the environment and animals to act as antibiotic resistant reservoirs. 
Molecular biologists differentiate the pan-genomes, which are a collection of the total 
gene make-up of the bacteria, into the ancestral genome (also called core genomes), and 
the dispensable genome. The latter is any additional genetic material that the bacteria 
acquired and can differ from strain to strain within species (Medini et al., 2005). 
According to reviews by Kelly et al. (2009), the transfer of genetic entities, including 
those carrying antibiotic resistance qualities, is highly possible in environments with high 
bacterial loads (Kelly et al., 2009a; Kelly et al., 2009b). This could occur through well-
known pathways used during horizontal gene transfers such as conjugation, transduction 
and transformation. Additional role players using these pathways to assist the bacterial 
strains to obtain antimicrobial resistance genes are plasmids, pathogenicity islands, 
transposons and integrons (Kelly et al., 2009a; Singh et al., 2005). 
I 
Plasmids in particular are known to play an active role in allowing the movement of 
genetic material, including antimicrobial resistance genes, between bacterial species and 
genera. They mediate resistance to multiple antimicrobials, the consequence being a 
pathogen acquiring resistance to all or most clinically relevant antimicrobials (Sherley et 
al., 2004). Conjugation allows transmissible plasmids and chromosomal DNA of even 
very large sizes to be transferred from cell to cell either within or outside the species, 
mediating antibiotic resistance through specified enzyme activities. Conjugative plasmids 
that have the capability to replicate independently in the newly acquired or recipient host 
have a greater chance of spreading through a bacterial flora community than those without 
conjugative abilities (Maurelli, 2006). The resulting increased potential of treatment 
failures of first-line antimicrobial drugs, hospitalisation and even death may necessitate 
administering additional second-choice drugs and prolonged treatments. 
Food animals exposed to additives, such as antimicrobials used for growth promotion, 
may serve as a reservoir of resistant bacteria and/or resistance genes that may spread to 
humans, thereby limiting the medical value of antimicrobial drugs in the latter (Aarestrup 
et al., 2001), although the ability of bacteria from animal origin to colonize the human gut 
and transfer resistance genes remains contentious (Phillips et al., 2004). Figure 1 provides 
a theoretical demonstration of how the use of antibiotics in food animal production may 
pose a human health risk. It is known that in the natural environment, such as soil and 
water, bacteria exchange genetic information (for example resistant genes) with great 
facility and lack of species specificity (Dessen et al., 2001). Mass therapy practice is a 
method used to treat large groups of animals, especially poultry, by supplementing their 
food or water supply. In the process, healthy animals are also treated, but the doses 
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received by each animal differ, as it depends on the amount of food and water that they 
each consume (Shea, 2004). 
Bacterial population 
( (resistance and susceptible) 
in farm animals 
I 
t :j, 
Antibiotics drug is given to Animal is given feed or water 
animals to prevent or treat treated with antibiotics for 
disease growth promotion 
I. 
I Antibiotic selects for bacteria J 
t 
I Resistant bacteria in animal mayor may not cause disease or infection 
I 
J J :J :j, , 
Spread of Spread of 
Spread of Spread of resistant 
resistant resistant bacteria bacteria to soil, well resistant bacteria 
bacteria to to farm workers water, and water to other animals 
consumers via and food runoff via r-on the farm via 
contaminated processors via contaminated animals interaction with handling of 
contaminated meat products contaminated t 
animals 1 animals or meat 1 Spread of resistant t bacteria to fruits and Spread of vegetables 
Bacterial transfer of resistant 
I resistance gene to other bacteria to fish 
bacteria j j 
Resistant disease or infection may develop in humans 
Figure 1: Demonstration of the theoretical transfer of antibiotic resistant genes 
potentially causing a public health risk (From GAO Reportl04-490) (GAO, 
2004). 
The largest obstacle in support of the termination of the use of antibiotics in food animals 
is the limited data available in the in-vivo and in-situ food chain environment. While gene 
transfer was reported in diverse environments, including animal and human intestinal 
tracts, animal faeces, human cell cultures, bovine rumen fluid, and sewage and surface 
waters (Walsh and Farming, 2008), the evidence of resistance via the food chain is mostly 
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circumstantial. A typical example of how an animal reservoir for resistant bacteria was 
concluded was the detection of nourseotricin resistant faecal E. coli in fann personnel in 
the former German Democratic Republic. Resistance to nourseotricin, a streptotricin 
antibiotic, was detected soon after its implementation in pig fanning production. 
Nourseotricin was not prescribed in human health care and it did not cause any cross-
resistance of bacterial strains to other antibiotics used in human health care. The resistance 
to nourseotricin was also later detected in human Shigella spp. not associated with animal 
origins. In addition, nourseotricin resistance was not detected in any neighbouring 
countries as it was never utilised for the local animal production and therefore in the 
absence of any reported human consumption, an animal resistant reservoir was therefore 
considered a likely source (Vanden Bogaard and Stobberingh, 1999). 
Another example is the presence of tetQ genes, which confer tetracycline resistance and 
are classified as 'ribosomal protection genes' (Chopra and Roberts, 2001) that were 
described in Bacteriodes spp. and Prevotella intermedius. Although these are host-specific 
commensal intestinal bacteria of humans, an identical tetQ gene was also described in 
Prevotella ruminicoia, which is a host-specific member of the commensal flora in cattle 
(Van den Bogaard and Stobberingh, 1999). TetQ genes are frequently linked to 
conjugative transposons and are expressed by both Gram-positive and Gram-negative 
bacteria (Chopra and Roberts, 2001). The question arises whether the tetQ gene in human 
commensal bacteria originated from an animal source or from an alternative source, 
including human tetracycline therapy. 
In 2000, a ban on the use of all antibiotics as growth promoters was originally 
implemented on the basis of a "Precautionary Principle", as the scientific evidence that its 
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contribution to the prevalence of resistant strains experienced in human health care was 
found to be inconclusive. The 'precautionary principle' acknowledged that although 
science was not yet able to provide plausible proof, the human risk was a major 
uncertainty factor (Van Asselt and Vos, 2006). In 2002, the "European Court of First 
Instance" (Luxemborg), following a ruling on the "Commission's Communication on the 
Precautionary Principle of 2000", ruled that the ban would continue as a "Precautionary 
Principle", as reports after the initial ban were contradictory and concrete scientific 
evidence was stiIllacking (Phillips, 2007; Van Asselt and Vos, 2006). As a result of these 
studies, the European Union banned the use of all antibiotics as growth promoters in 
animal food from 1 January 2006. In the UK, antibiotics used to improve growth 
efficiency can be purchased as prescription-only medicines (Sarmah et a!., 2006). 
The tennination of antibiotic use and the implementation of more efficient regulations 
regarding the use of veterinary antibiotics were a direct result of multiple studies around 
the world reporting antibiotic resistance of clinical isolates, particularly bacteria strains 
associated with zoonotic diseases (Aarestrup et al., 2001; Sarmah et al., 2006). However, 
the effectiveness of the ban is difficult to evaluate, as it is evident that it depends on how 
and what data is interpreted. Persons travelling across district and country borders, as well 
as the import food markets (from countries where other and/or more lenient food 
production regulations concerning antimicrobial usage are followed), have complicated 
scientists' efforts to arrive at strong conclusions about the effect of the ban on human 
health (Hammerum et al., 2007). A typical example of these difficulties is the low 
quinolone resistance of Campylobacter jejuni (8 %) from poultry reported in the 2005 
Danish Integrated Antimicrobial Resistance Monitoring and Research Programme 
(DANMAP), in contrast to the higher 29 % clinical resistance reported in humans 
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(DANMAP, 2005). DANMAP has provided intermediate surveillance reports since 1997, 
and is one of the few reports that have provided some continuity in a specific region or 
country since before the ban. 
Given the present knowledge of horizontal resistance transfer, co-resistance and co-
transfer across bacterial species, the potential risk to human health is serious if food 
animals become reservoirs of resistance. However, models created to calculate the risks 
are yet to conclusively explain how much antibiotic usage in food animal production 
would result in resistance of subsequent human use of related drugs (Bailar and Travers, 
2002). Increased therapeutic use of antimicrobials to maintain animal welfare of food 
animals was further argued to be contributing to the discrepancies found in the 
antimicrobial resistance surveillance reports after the ban (Bengtsson and Wierup, 2006). 
This increased therapeutic antimicrobial usage could also have emerged following other 
opportunistic sources of infection that materialised after the ban, and may not necessarily 
have been as a direct result of the ban on growth promoters (Phillips, 2007). Data on 
human clinical isolates provided after the EU 2006 ban is further skewed by the increased 
therapeutic prescriptions in the EU human health care system, such as higher prescribed 
doses as a result of increased pharmacological understanding of certain antibiotics 
(Hammerum et al., 2007). It is thus difficult to conclude what the effect of the EU ban was 
even after being in effect for more than 15 years, notwithstanding simultaneous influential 
changes that took place in other areas of the health care (human and animal) systems. 
Despite international concern, South Africa has not followed similar barming restrictions 
set by the EU, and the debate on the use of antibiotics in food production has been less 
prominent from a public health perspective. However, some public concern does exist, and 
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South Africa may encounter international pressure to ban the use of antibiotics in food 
animal production, particularly in those reared for export (Didiza, 2006). The Animal Feed 
Manufacturers Association (AFMA) acknowledges the responsibility that producers have 
when using antimicrobials for food production, specifically those related to human health 
care (AFMA, 2006). AFMA further states that the prudent use of antimicrobials according 
to "Global Basic Principles" (WHO, 2000) should be followed but adapted for the local 
legislation and regulations of a country. The adaptation in South Africa involves the 
registration of therapeutic antimicrobials under the 'Medicines and Related Substances 
Control' Act 101 of 1965, which allows for their prescription by a veterinarian, while 
growth promoters are registered under Act 36 of 1947 as 'Stock Remedies', and require no 
veterinary supervision (Table I) (AFMA, 2006). 
Table 1: South African antimicrobial drugs of relevance to the study intended for human 
health that are registered antimicrobial feed additives (growth promoters) and/or 
ethical (scheduled) antimicrobial drugs (Swan et at., 2007). 
Growth 
Scheduled drugs (Act 101 of 1965) 
Class Antibiotic promoters 
(Act 36 of 1947) 
Main indications 
Beta-Iactams Amoxicillin NO YES 
Infections caused by a variety 
of susceptible organisms 
Oxytetracyclines YES YES Tick-borne haemo-parasitic 
Tetracyclines Chlortetracycline YES YES diseases 
Respiratory tract infections 
Enrofloxacin NO YES Respiratory tract infections 
Quinolones Norfloxacin NO YES Bacterial and mycoplasmal 
infections in poultry only 
Aminoglycosides Neomycin NO YES Bacterial enteritis 
Tylosin YES YES Mycoplasmal infections 
Macrolides Swine dysentery 
Kitasamycin YES NO Respiratory tract infections 
7 
DOCTOR OF PHILOSOPHY: Bester LA (2013) 
The first report of the South African National Veterinary Surveillance and Monitoring 
Programme for Resistance to Antimicrobial Drugs (SANV AD) showed that indicator 
organisms in healthy animals had reached concerning levels of resistance, this being 
attributed to the antimicrobial usage in the food production industry. Escherichia coli in 
poultry showed a prevalence of resistance to oxytetracycline (> 90 %), enrofloxacin (65 
%), ampicillin (-28 %), trimethoprim (-32 %), neomycin (20 %), gentamicin (-7 %), 
sulfamethoxazole (> 85 %), nalidixic acid (-63 %) and ceftiofur (-3 %). It also showed 
resistance to chloramphenicol (-24 %), which has been banned since 1980, this rather 
being attributed to the use of florfenicol, a chloramphenicol analogue, registered for use in 
other food animals (cattle and pigs) (SANV AD, 2007). Cross-resistance may explain this 
resistance, while co-transfer of resistance may explain the phenomenon of 
chloramphenicol resistance in poultry E. coli, in the absence of chloramphenicol and 
florfenicol, but following phenicol exposure (Bywater et al., 2004). 
In a European Commission (EC) report of 1999, 14 key human pathogenic bacteria were 
listed and of those, only four bacterial strains were recognized to have animal origins: 
Campylobacter, Salmonella, E. coli and Vancomycin-resistant Enterococci (Follet, 2000). 
A variety of animals are thought to be asymptomatic reservoirs of Campylobacter spp. 
including food animals such as pigs, poultry (including turkeys) and cattle (WHO, 2011). 
It is only since the late 1970s with the development of more specialized techniques to 
isolate Campylobacter enhanced an awareness about its potential risk to public health. 
Campylobacter is a small Gram-negative spiral shaped rod that grows in micro-aerophilic 
atmosphere on medium that is supplemented with blood or blood substitute (Lastovica, 
2006a). Presently, the genus comprise of 17 species of which C. jejuni spp. jejuni (further 
referred to as C. jejuni) and C. coli are the most common human pathogens (WHO, 20 II), 
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although other species, namely C. lari and C. upsaliensis, have also been identified, but 
are prevalent to a lesser degree (Lastovica, 2006b; WHO, 2011). 
Humans are normally infected by Campylabaeter bacteria through an oral pathway by 
handling and consuming uncooked meat, especially poultry products, contaminated water 
and even raw vegetables (Chai et al., 2007; Wilson et al., 2009). Campylabaeter cause 
gastroenteritis in humans, also known as campylobacterioses, and is normally considered 
self-limiting diarrhoea (Van Vuuren et al., 2006). However, cases of bacteraemi~ 
pancreatitis and hepatitis have been reported as complications. Post-infection links 
campylobacterioses to arthritis and the neurological Guillain-Barre syndrome, although 
this has been observed less frequently. Children, the elderly and immuno-compromised 
patients are particularly vulnerable, and infection may result in death (WHO, 2011). 
Campylabaeter spp. have also shown to be important pathogenic opportunists in under-
nourished children in South Africa (Mackenjee et al., 1984). 
Campylobacterioses is the most prevalent of all the foodbome diseases in the EU, with the 
cost to the health sector and employers regarding its impact on productivity being 
estimated to be EUR 2.4 billion per annum (EFSA, 20 II). It is not known what the impact 
of Campylabacter-related diseases is in South Africa as no continuous surveillance 
programme in human and animal health care has been implemented to date, although 
sporadic research on its prevalence and resistance in both human and animal health has 
been reported (Jonker, 2009; Lastovica, 2006b; Samie et al., 2007). 
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1.2 Problem Statement 
In South Africa, antibiotics used as growth promoters in animals are regulated under the 
Department of Agriculture Act 101 of 1965 (Swan et al., 2007), although these regulations 
are not as stringent as they are in the EU countries. There is however, a corporate 
awareness of the responsible usage of antibiotics in animal food production and the need 
to prevent the emergence of antibiotic resistance reservoirs in food animals (AFMA, 2006; 
South African Poultry Association, 2008). Despite this there is limited research and little 
public awareness of the probability of antibiotic resistance dissemination via the food 
chain in South Africa, necessitating a study of this nature. 
1.3 Aim 
To investigate the prevalence of antibiotic resistance m the food chain usmg 
Campylobacter spp. in poultry as a case study. 
1.4 Objectives 
• To isolate Campylobacter spp from caeca of poultry reared in rural, free-range and 
industrial production systems. 
• To phenotypically and genotypically identify the Campylobacter spp. ascertaining 
the sensitivity, specificity, positive-predictive value and negative-predictive value of 
biochemical methods and the new matrix assisted laser desorption ionization- time 
of flight (MALDI-TOF) mass spectrometry with polymerase chain reaction as the 
gold standard. 
• To ascertain antibiotic resistance profiles of Campylobacter spp. using the agar 
dilution method of the Clinical and Laboratory Standards Institute. 
• To ascertain plasmid profiles of Campylobacter spp. using alkaline lysis method. 
10 
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• To ascertain the number of genotypic strains using pulse-field gel electrophoresis. 
• To analyse the phenotypic and genotypic similarities and/or differences within the 
different farming systems. 
11 
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dissemination of antibiotic resistance via the food chain, the second paper confirmed that 
antibiotic resistance is a function of time and use by comparing the antibiotic resistance 
profiles of broiler and layer chickens in a single industrial poultry production system. The 
third paper presented the impact of selection pressure by describing antibiotic resistance 
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identification methods, strains and plasmid profiles on a representative sample of isolates 
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The me'chanisms that. bacteria use to acquire additional genetic material, including g'eIJ.es codlng 
for antibiotic resistance, are principally the secondary pathy,rays 'that- have been described as 
transfofmation and conjugation pathways. The farn1ing industry often is reported as a hutspot fbr 
antibiotic-resistance reservoirs. In this review, we consider the exposure of food animals duringJhe 
course-of their lifespans to preventative, therapeutic or prophylactic treabnent with,antibiotic agents. 
In this context, zoonotic bacteria are commonly recognis,ed as a potential threat to h"\1man health, 
with therapeutic trealritent of p~l.thogenj.c orgallisms. on farms increasmg' the likelihood of selective 
antibiotic pressure influencing the commensal flQra of tl:le inte$tin:es. Existing literature indicates, 
however, that the effective, imp.ad on human health 'of such interventions· in the food production 
process is still subj¢ct to: d~bate. 
INTRODUCTION 
Medini et aL l refer to the total genetic makeup of an individual bacterium species as the pan genome. 
They further differentiate the pan genome into the ancestral or core genome and the dispensable 
genome, which comprises additional or acquired genetic material and can differ between strains within 
a species. In situations in which bacteria carrying acquired genetic material are hosted by food animals, 
the question arises as to whether exposure of these food animals to therapeutic and/or prophylactic 
antibiotic treatments creates a potential threat to human healthY We review whether a specific gene 
encoding a particular antibiotic-resistant gene element, originally present in a bacterium derived from 
a food animal source, can be the same gene encoding antibiotic resistance subsequently residing in a 
human clinical isolate of a totally different baderial strain, species or genus. 
TRANSFER OF ANTIBIOTIC RESISTANCE 
Acquired antibiotic resistance is attributed to both direct and indirect pathways. Direct or primary 
pathways are mutations in the gene encoding resistance against the mechanisms of particular antibiotics. 
The most commonly known example is resistance of Mycobacterium tuberculosis to streptomycin that is 
associated with an adaptation of the ribosomal sites.4,S,h Indirect or secondary pathways are the gaining 
of small fragments of DNA coding for resistance. These indirect pathways for resistance acquisition can 
be further sorted into three categories: transformation, conjugation and transduction.4,7 
Transformation 
Theoretically, even a dying bacterium cell may release its plasmids, or short fragments of its DNA into 
the environment, which allows for the possibility for a healthy bacterium cell, called a recipient. to 
acquire this material (and use it for its own benefit) directly through the cell walL This kind of transfer 
via the cell wall is known as the transformation pathway. However, our present knowledge of this 
fOrn1 of genetic transportation indicates that it has limitations; for bacteria, such an action can only be 
executed if the bacterium has the requisite genetic capacity to absorb 'loose' compatible DNA- usually 
in a plasmid fonn - and, to present knowledge, can only occur in a limited number of bacteria. However, 
some scientists believe that this pathway usage by bacteria is underestimated.4.?A9 
Conjugation 
Conjugation allows transmissible plasmids and chromosomal DNA of very large sizes to be transferred 
from cell to cell, either within or between species, mediating the transmitted genetic material through 
variously speCified enzyme activities. The conjugational pathway does not select DNA material simply 
from the environment, as in the case of transformation, but instead has a direct cell-to-cell exchange 
of genetic material, where one cell is the donor of the genetic material and the other the new host or 
recipient. The conjugation pathway uses a very specific, hair-like attachment on the surface of the 
bacterial cell, construded mainly of oligomeric pilin protein, that acts as a bridge pulling the two cells 
together.4 Enzymes further initiate the transportation of a single DNA strand to the new host, where both 
cells synthesise duplicates. Both the cells can now act as donor cells. Additional role players that use 
such pathways to assist the bacterial strain to obtain advantageous characteristics (such as antimicrobial 
resistance and pathogenicity) are plasmids, pathogenicity islands, transposons, integrons?,10 and 
insertion sequences.]) Conjugative plasmid..,> that have the ability to replicate independently in the 
newly acquired (recipient) host have greater opportunity to spread through a bacterial flora community 
than those without conjugative abilities.9 Gentamycin-resistant Staphylococcus aureus, for example, 
reflects the presence of amino glycoside acetyltransferases and aminoglycoside phosphotransferases -
enzymes responsible for drug inactivation - and is encoded on a gene Iaac(6')-Ie+aph(2")] located on the 
transposon Tn400l. This transposon is common in S. aureus isolates and is also found on conjugational 
plasmids. The aac gene is not specific to Gram-positive bacteria as it has been found to cause multi-
drug resistance in Enterobacteriaceae isolates.12 The tetracycline-resistant tef(Q) gene is often found 
simultaneously with the erythromycin-resistant erm(F) gene on a conjugative transposon, resulting in 
multi-drug resistanceY But it is unclear whether the transfer of genetic elements through conjugation 
occurs voilU1tarily or equally between both cells (that is, whether both cells actively seek to exploit the 
possibility of transference) or whether a scenario of cell 'hijacking' takes place for the sake of survival of 
a more aggressive genetic element.14 
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Transduction is the virus-like injection of genetic material into 
a host cell after attadunent. To the best of current knowledge, 
transduction is a feature mainly of bacteriophages commonly 
acting as bacterial viruses/ and is not directly relevant to the 
present discussion. 
ANIMAL RESERVOIRS OF ANTIBIOTIC 
RESISTANCE 
The fanning industry is often alluded to as a hotspot for reservoirs 
of antibiotic resistance. During their lifespan,. production animals 
are often subjected to preventative, therapeutic or prophylactic 
treatment with antimicrobial agents. Although. subtherapeutic 
use of antibiotics in animal production is commonly considered 
to be a major contributor to the proliferation of antibiotic 
resistance amongst environmental bacteria, Ghosh and LaPara6 
concluded that the clearance of the animal pens of manure, 
followed by its subsequent disposal, had a greater impact on the 
lateral transfer (also known as horizontal transfer) of tet genes 
coding for antibiotic resistance amongst soil bacteria. In their 
study, manure that was allowed to accumulate on soil produced 
greater antibiotic resistance in natural soil bacteria. In addition, 
bacterial isolates from soil samples collected closer to the animal 
pens produced higher antibiotic resistance than those from a 
further distance. Generally, animals also have a high. level of 
exposure to their environment, especially the soil environment, 
making it easier for them to be infected with bacteria that carry 
problematic genetic elements. D'Costa et al.15 undertook a study 
on the antibiotic-resistance profiles of strains of soil bacteria that 
were chiefly from the familiar antibiotic-producing Streptomyces 
genus. They highlighted the high antibiotic resistance and 
multi-drug resistance found in the natural soil environment and 
concluded that it was possible that these soil sources could act as 
a reservoir for resistant elements.J5 Natural antibiotic-producing 
organisms mutate for the sake of survival in competition with 
other organisms sharing the same ecological environment. It 
was shown that erythromycin-resistance in S. aureus, caused 
by a plasmid, and corresponding resistance in soil bacteria, 
Streptomyces erythraeus, have a similar genetic mutation of the 
23SrRNA. Methylation of this region is a natural process for 
the latter erythromycin-producing organism, suggesting that it 
could have originated from this source. If, 
As with humans, animals also are susceptible to diseases that 
necessitate therapeutic treatment. However, treatments of 
pathogenic organisms in a farming context heighten selective 
antibiotic pressure that influences the overall commensal flora 
of the intestines. While treating for mastitis caused by S. aureus 
in cattle (in Meylan, France), researchers located an R-plasmid 
(resistant plasmid), pIMS1 in Escherichia ClJli, hosted in the 
cattle and in the local veterinarian and some of the other animal 
handlers.17 These findings were very similar to those reported 
in a groundbreaking study by Levy et a1. in 1976,18 in which the 
intestinal bacterial flora of fann personnel were studied after 
introduction of an antibiotic supplement to the animals' feed. 
The antibiotic was a low-dose, broad-spectrum tetracycline; 
within six months of its introduction, 31.3% of weekly faecal 
samples taken from fanning personnel contained more than 
80% tetracycline-resistant bacteria, compared with 6.8% of 
samples taken from neighbouring farm personnel who were 
not exposed to the farm animals.1B Since then. it has been shown 
that tetracycline resistance may be caused by efflux proteins, 
'ribosomal protection genes', or antibiotic inactivation enzymes, 
expressed by anyone of a wide range of tet genes, which have 
been sequenced for both Gram-positive and Gram-negative 
bacteria. 12, 13 
ZOONOSES 
Bacteria, normally associated benignly with animals, can also 
have natural qualities that allow them to replicate in humans 
with deleterious disease consequences. These bacteria have a 
greater chance of being vectors of antibiotic-resistant genes. 
Bester, Essack 
South African veterinarians working in constant close proximity 
with farm animals have a three-fold greater likelihood of being 
infected with a zoonotic disease than their counterparts in the 
small-animal or other research fields. 19 This figure is highly 
significant when we consider how many people in South Africa, 
and in Africa generally, live in secluded or rural areas in close 
proximity to farm animals, with possible exposure to zoonotic 
bacteria. Zoonotic bacteria with pathogenic capabilities are 
generally a threat to the human health system, and more so 
if they become resistant to the antibiotics nonnally dictated 
for treatment. Geonaras et al. 20 undertook a susceptibility 
study of E. coli strains collected in poultry, measured against 
five antimicrobial agents used in the South African poultry 
industry. All strains showed susceptibility to danofloxacin 
and colistin, while 96% were resistant to two tetracyclines.20 
Moreover, in figures for antibiotic susceptibility of potentially 
human pathogenic bacteria isolates clinically, as well as from 
healthy farm animals, published in the first report of the South 
African National Veterinary Surveillance and Monitoring 
Programme for Resistance to Antimicrobial Drugs (SANVAD), 
both E. coli and Enterococcus species showed increased antibiotic 
resistance, but equivalent to that of comparative profiles from 
European counterparts. The highest resistance was reported 
for tetracycline and sulphonamides and the lowest resistance 
for ceftiofur (a third-generation cephalosporin). Highlighted in 
the report was evidence of E. coli isolates obtained from abattoir 
chickens, which showed higher resistance for tetracyclines, 
fluoroquinolones and sulphonamides, in particular, than isolates 
obtained from clinically ill chickens.21 
In addition to zoonotic bacteria acquiring antibiotic resistance, 
pathogenicity can also be increased by the addition of virulent 
genetic elements. For example, in Ireland, a potential epidemic 
clone of Salmonella entirica serotype Typhimurium DTI04 was 
detected in human gastroenteritis isolates, veterinary isolates, 
and food samples, with 78% of the isolates showing simultaneous 
resistance against ampicillin, chloramphenicol, streptomycin, 
sulphonamides and tetracycline.21 Similar resistances were 
found in the United States, France, Sweden, Russia and Canada 
for Salmonella serotypes as well as for E. coli and Campylobacter 
species.2J The step-wise partial or complete banning in various 
countries of antibiotics used in food animal production was 
primarily in response to results reported on clinical zoonotic 
bacteria. However, the reported bacterial resistance profiles 
varied from country to country. Aquino et al.24 relate the 
inconsistencies between antibiotic resistance profiles to the way 
therapeutic and prophylactic treatment of humans and animals 
was exercised in different demographical and geographical 
areas. The clinical resistances found were correlated with each 
country's regulations on the use of specific drugs for certain 
groups of food animals. Australia, for example, did not allow 
fluoroquinolones to be used in commercial food production 
and only cooked meat products were allowed to be imported, 
a fact which might explain why clinical fluoroquinolone-
resistant Campylobacters were rarely detected in Australia, in 
comparison to what was experienced by other countries at the 
time.25 The European Union consequently banned the use of all 
antibiotics as growth promoters as from 01 January 2006. In the 
United Kingdom, antibiotics used to improve growth efficiency 
have been restricted as prescription-only medicines.Z6 
FOOD ANIMALS AS A SOURCE OF 
ANTIBIOTIC RESISTANCE 
It is difficult to prove that a specific gene (e.g. coding for antibiotic 
resistance) has been transferred from a food animal source and is 
now residing in a pathogenic human clinical isolate in a different 
bacterial strain, species or genus. However, two general opinions 
exist as to whether food animals can act as a source of a human 
pathogenic antibiotic-resistant bacteria. 
The first opinion is that food animals exposed to additives such 
as the antibiotics used for growth promotion may serve as a 
reservoir of resistant bacteria and/or resistance genes that may 
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spread to the human population, thereby limiting the medical 
value of antimicrobial drugs.3 
The initial efficacy of antibiotics in food animal production 
and, specifically, as growth promoters, was achieved through 
(1) stabilising the gut microflora by suppressing subclinical 
pathogenic populations, (2) enhancing protein metabolism by 
improving digestibility and nitrogen upkeep, (3) enhancing 
vitamin production by gastrointestinal microorganisms, and 
(4) increasing intestinal absorption of nutrients by the host.lJ.27 
The practice of mass treabnent of animals such as poultry by 
supplementing their food or water supply is of particular 
concern when considering the development of antibiotic 
resistance because, as the animals compete for food sources, the 
doses received differ between individuals. The consequence of 
some individuals receiving higher doses than others introduces 
another differential in the selective pressure on commensal 
bacteria28 and opens the possibility for the transfer of genes 
encoding for antibiotic resistance and multi-drug resistance. 
For example, E. coli strains from commensal environments 
act as reservoirs of genes, such as class 1 integrons, with both 
antibiotic-resistant and transferable qualities; these genes can be 
horizontally transferred throughout a bacterial popUlation and 
carry several antimicrobial resistance cassettes. lO 
The existence of transfonnational and conjugational pathways 
was demonstrated when qnr genes, coding for quinolone 
resistance, were transferred in the laboratory from human 
clinical non-Typhi S. enterica serotypes to an E. coli J53 strain. 
These variants of the qnr were found to be widely distributed 
across different states of the United States and found in a 
variety of arumal hosts.29 Kruse et apo demonstrated the transfer 
of R-plasmids by conjugation after preparing an Aeromonas 
salmonicida subsp. salmonicidtl NVH4133 (recipient)-infected fish 
(salmon) on a plastic cutting board infected with E. coli DH5 
cells (donor). They were also able to demonstrate the transfer 
between pathogenic bacteria in various other environments, 
including a hand towel and pig faeces . .}!) 
Meat and meat products seem to be particular loci of antibiotic-
resistant bacteria. Contamination of meat can occur during 
carcass processing if the rumen is accidentally cut. In the case 
of poultry, the intestine may rupture when the carcass is gutted 
during processing, releasing its contents into the thoracic and 
abdominal cavities.31 The gut contents of chickens, especially of 
the caeca, are considered to be peak envirorunents for bacterial 
colonisation, providing a ready platform for the transfer of 
genetic entities7,8 with subsequent spreading to other meat 
products that emanate from commercial abattoirs. The Danish 
Integrated Antimicrobial Resistance Monitoring and Research 
Program (DANMAP) reported laboratory studies of the 
exchange of vanA genes in the intestines of mice and humans 
that code for vancomycin resistance. Special concern was raised 
for meat contaminated with enterococci transferring their vanA 
genes to human pathogenic E. jaecium isolates,32 Retail 'ready-
to-eat' foods could present particular risk because they are 
consumed as purchased, rather than undergoing subsequent 
cooking. 
Products containing poultry, beef and pork in Mirmeapolis, 
United States, were found to be contaminated with resistant 
E. coli and extraintestinaI pathogenic E. coli carrying additional 
virulent factors. These findings corresponded closely with the 
prevalence of contamination found for animal carcasses exposed 
to immediate contamination from the intestines, as well as for 
processed meat further along the production line.33 
This fonn of meat contamination was also found in Addis 
Ababa, Ethiopia, where 8% of the beef samples collected 
were contaminated with E. coli 0157:H7, but less than 2.5% of 
sheep and goat meat samples were contaminated. This lower 
contamination rate was attributed to the lower faecal prevalence 
of E. coli 0157:H7 in sheep and goats. The meat contamination 
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rates thus corresponded closely with the prevalence rates in 
the respective hosts. The samples collected from butcheries 
also yielded higher contamination rates than those from 
abattoirs, including an export abattoir.34 E. coli 0157:H7 is a well-
recognised pathogenic invasive strain of E. coli; Mizan et al.35 
have demonstrated the strain's susceptibility to the acquisition 
of resistant plasmids in laboratory conditions using bovine 
rumen fluid. 
Following ingestion, either the complete bacterium starts to 
colonise the human digestive system or the genetic resistant 
elements are transferred to commensal or pathogenic E. coli 
strains in the human intestines, causing food-borne disease. 
The antibiotic-free labelling of production animal food sources 
apparently fails to take into account potential subsequent 
contamination during the processing of the food products.33,:lI; 
Generally, bacteria with or without resistant genes present in 
the meat are killed in the course of cooking the meat. But the 
potential for infection still persists in contamination of the 
preparation environment, if, for example, hands are not washed 
properly or the same utensils are used. to prepare both meat 
and salad dishes. In Malaysia, Chai et al.37 frequently isolated 
Campylobacter jejuni and Campylobacter coli from raw vegetables 
used for popular salad dishes, probably attributable to animal-
contaminated irrigation water.3? The latter instance signals 
how easily bacteria nonnally associated with animals can be 
sustained in non-animal environments. 
The second general opinion is that concerns of food animals being 
the major source of antibiotic-resistant genes are unfounded. 
Phillips et aI,38 believe that the likelihood that bacteria from food 
origin have the ability to colonise the human gut and transfer 
resistance genes is low, and that, if the possibility did exist, the 
clinical consequences would be insignificant.31:1 
Food animal production usually incorporates some fonn 
of antibiotic usage, either therapeutic or prophylactic. But 
horizontal transfer of genes coding for antibiotic resistance 
happens with ease, even without selective pressure imposed 
bY.the presence of antibiotics.6 According to Kruse et al.30, the 
transfer of plasmids in faeces indicates that conjugational transfer 
of R-plasmids takes place in the digestive tract, irrespective 
of antibiotic usage. It appears that transfer can occur between 
bacteria of diverse origin - humans, food animals, fish and even 
sea water.30 According to reviews by Kelly et a1.,1-8 the transfer 
of genetic entities, including those carrying antibiotic-resistance 
qualities, becomes all the more probable in environments with 
high bacterial loads. 
In rural areas in developing countries, there is a high risk 
of exposure to food animals, and thus exposure to zoonotic 
bacteria,I9 even though the use of antibiotic growth promoters 
may not be a nonnal farming practice. The most common 
poultry production systems in these localities consist of 
indigenous-species animals in small numbers (i.e. less than 50) 
that rely on scavenging as a feed source.J9 Dhlamini40 reported 
that 87% of family poultry systems studied in KwaZulu-Natal 
used traditional remedies originating predominantly from 
plant material, although commercial products, in particular 
Terramycin and, to a lesser degree, potassium permanganate, 
also were used for treating the animals. Thus the resistance found 
in clinical samples from developing countries may have different 
origins to that found in developed countries. The 70th Report 
of the Joint FAD/WHO Expert Committee on Food Additives 
(JECFA)41 presents evaluations of certain veterinary drugs for 
subsequent drug residues in food products destined for human 
consumption. The report states that within a few hours of oral 
administration, more than 30% of ingested. tylosin (a macrolide 
antibiotic) was bound to the faeces inside the intestinal tract of 
the animal, reducing the antimicrobial activity of the antibiotic. 
The antibiotic itself undergoes chemical breakdown as it passes 
through the digestive system, further reducing its antimicrobial 
activity.41 So although tylosin is in the same antibiotic class as 
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erythromycin, which is used in human treatment, it does not 
remain active in the digestive system to initiate bacterial stress. 
THE HUMAN CONTRIBUTION 
In recent decades, veterinary and agricultural practices have 
come under frequent censure for their role in establishing 
and spreading antibiotic-resistant bacteria. At the same time, 
as noted in the Danish DANMAP report32, there has also 
been increased clinical use of antimicrobials in human health 
care, probably because of an improved understanding of the 
pharmaceutics of antibiotic drugs, which has often resulted in 
higher dosages, increased hospitalisations, but shorter hospital 
stays,n In addition to this, the quantity of antimicrobials being 
used in human health systems is further augmented by drugs 
prescribed in the treatment of syndromes (e.g. AIDS), where the 
antimicrobials are not necessarily pathogen-specific.~z European 
human epidemiological shtdies have shown a wide presence of 
integrons, including integron 1, with additional gene cassettes 
coding for various forms of resistance.12 The origin of the host, 
namely humans, is suspected to contribute to the way gene 
transfer occurs. For both humans and other animals, the bacterial 
flora in the gut is significantly determined from birth by the 
host's diet and environment (prior to birth, the digestive tract 
is bacteria-free). Not only is the evenhtal composition of the gut 
flora in adults dictated by this early colonisation of the gut, but 
it is also uniquely shaped for each individual by the present and 
future welfare, and environmental hygiene to which a newborn 
is exposed.43,44,45,46 AdJerberth et a1.45 reported that breastfeeding 
and environmental exposure resulted in increases in pathogenic 
Gram-negative bacteria in the gut flora of newborns in Sweden 
(a developed country) and Pakistan (a developing country)Y 
This initial establishment of the eventual composition of the gut 
flora dictates the host's future immune response and prevents 
colonisation of foreign bacteria.4.' Mechanisms, not yet well 
defined, seem to assist in the establishment of the microbiota and 
it is speculated that there is a very specific relationship relating to 
the host-microbe interaction. 48 There is a clear likelihood that this 
relationship, founded in infancy and speCific to each individual, 
could also be disturbed by the early administration of antibiotics 
and even probiotics. It has been suggested that clinical treatment 
should be based on the unique microbiota of each individual~~­
a possibility with future technology development. 
CONCLUSION 
A large amount of information on the transfer of antibiotic-
resistance genes has been derived from developed countries, 
including the prevalence of antibiotic resistance in food animals, 
the possible correlation to human health, subsequent antibiotic 
management strategies and ongoing surveillance programmes 
that have often led to new legislation and regulations. Molecular 
tools have highlighted genes linked to known, unknown 
and undefined bacteria.27 The influence of these unknown 
organisms on the transfer of antibiotic resistance is speculative. 
Early-infancy colonisation of the gut determines the future 
bacteriological welfare of an individual. Taking into account the 
divergences in healthcare systems (including the prevalence of 
acute and chronic diseases with accompanied short-term and 
long-term antibiotic therapy), economic welfare and culhtral 
habits, the average gut bacteria composition for African people 
is likely to be distinct from their Western counterparts. In all 
probability; bacterial evolution is a continual process determined 
by a survival strategy. Our focus on the continually changing 
micro-environment of bade ria has undoubtedly become sharper 
as we view it through 'the lens of antibiotic resistance'. 
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Objectives: Campylobaeter jejuni isolated from broiler and layer chickens from registered abattoirs in 
KwaZulu~Natal, South Africa, were tested for their susceptibility to eight antibiotics. 
Methods: Using agar dilution, susceptibility to eight antibiotics was determined for C. jejun; recovered 
from the caeca. 
Results: A total of 155 isolates were collected of which 77 were identified as C. jejuni (broilers n = 56 
and layers n = 21). Resistance was highest to tetracycline (broilers 98.2% and layers 100%) and ceftriaxM 
one (broilers 96.4% and layers 100%). High susceptibility was found to ciprofloxacin (broilers 91% and 
layers 76%) and gentamicin (broilers 980/ 0 and layers 81%). Susceptibilities to each of the antibiotics for 
the broilers and layers, respectively, were: 50% and 5]0/0 for erythromycin, 45% and 24% for clarithromYM 
cin, 68% and 43% for ampicillin and 64% and 48% for nalidixic acid. Statistically significant differences 
were detected for the MICso of gentamicin, ciprofloxacin and tetracycline between broilers and layers 
(P<O.OOl) with the MICgo of gentamicin also of significant difference (P= 0.(1). Multiresistance was 
detected in 23% and 43% of the isolates from broiler and layer chickens, respectively. 
Conclusions: Mass therapy procedures used in animal husbandry have a potential impact on antibiotic 
resistance development in C. jejuni. 
Keywords: Campy/obaeter jejuni, antimicrobial resistance surveillance, food animals, growth promoters, animal 
reservoirs 
Introdnction 
Although banned in the European Union, many developing 
countries use antibiotics sub-therapeutically as growth promoters 
and as prophylaxis, usually as food/water supplements. 
Campylobacter species, especially Campylobacter jejuni and 
Campylobacter coli, are known zoonotic bacteria causing sympto-
matic diarrhoea in humans. I Humans are normally exposed to 
Campylobacter spp. through an oral pathway by handling and con-
suming uncooked meat, especially poultry products, faecal con-
taminated water and even raw vegetables.2 Campylobacteriosis is 
generally described as a self-limiting disease that rarely requires 
antimicrobial intervention. 
The aim of this study was to detennine the susceptibility 
profiles of C. jejuni collected at slaughter from commercially 
produced broilers and layers in KwaZulu-Natal. Antibiotic 
susceptibility was detennined for antibiotics commonly used in 
human therapy for Enterobacteriaceae infections in humans, 
namely fluoroquinolones, quinolones, tetracyclines, macrolides, 
aminoglycosides and [3-lactam antibiotics (cephalosporins and 
penicillins). 
Materials and methods 
Bacteria isolation 
Ethical approval was granted by the University of KwaZulu-Natal 
(AEIBester/06). Caecal samples were collected from conunercial 
broiler and layer chickens soon after slaughter from four registered 
chicken abattoirs in KwaZulu-Natal. Samples were filtered on 
Butzler plates and incubated at 41SC in a rnicro-aerophilic atmos-
phere (CampyGen, Oxoid) for 48 h. 
*Corresponding author. Tel: + 27 -31-2607671; Fax: +27-31-2607730; E-mail: bester!@ukzn.ac.za 
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Identification 
Campylobacter spp. were screened using conventional methods for 
campylobacters, which included oxidase and catalase tests, charac-
teristic niorphology after Gram stain, hippurate hydrolysis and sus-
ceptibility to nalidixic acid and cefalotin. 
Antibiotic susceptibility testing 
MICs were detennined by agar dilution using a modification of 
Columbian agar supplemented with 7% lysed horse blood and 
Campylobacter growth supplements (Oxoid). Except for erythromy-
cin, breakpoints for ciprofioxacin, tetracycline, ceftriaxone, clari-
thromycin, ampicillin, nalidixic acid and gentamicin were adapted 
from those used for Enterobacteriaceae: ciprofioxacin, MIC::; 
1 mg/L; tetracycline, MIC::; 4 mg/L; ceftriaxone, WC :::; 8 mgIL; 
clarithromycin, MIC ::; 2 mg/L; ampicillin, MIC ::; 8 mgIL; nalidixic 
acid, MIC ::; 8 mg!L; and gentamicin, WC ::; 4 mg/L? A proposed 
guideline was followed for erythromycin: MIC ::; 8 mgIL.4 
Escherichia coli (ATCC 25 922) and Pseudomonas aeruginosa 
(ATCC 27853) were used as controls. STATA was used to analyse 
percentile values. 
Results 
Of the 155 samples, 77 were identified as C. jejuni, of which 56 
were collected from broilers and 21 were collected from layers. 
Table 1 shows the percentage resistance and MICso and MIC90 
results with significant differences between broilers and layers 
evident for ciprofioxacin, tetracycline and gentamicin. 
Multiresistance, described as resistance to four or more anti-
biotics, was detected in 23% and 43% of the isolates from 
broiler and layer chickens, respectively. 
Discussion 
Fluoroquinolones and macrolides are the drugs of choice for 
early treatment of campylobacteriosis.s The prevalence of cipro-
ftoxacin resistance is a cause for concern, especially for the 
layer chickens (24%) that do not have as intensive exposure to 
antibiotics as do the broilers. Approximately half the isolates 
from the broilers (50%) and layers (47%) were resistant to 
erythromycin. 
Even though layer chickens are not continuously exposed to 
growth promoter antibiotics in their feed, in the long run the 
therapeutic use of some drugs does have the potential to affect 
the susceptibility of C. jejuni when one considers the nature of 
poultry production. Normal commercial production methods 
make it difficult to treat individual animals mainly because of 
the large numbers of animals grouped together; thus, mass medi-
cation is the only option. However, addition of antimicrobial 
agents to water or feed may result in individual animals receiv-
ing inadequate curative doses or excessive prophylactic doses. 6 
Such production practices may result in reservoirs of resistant 
C. jejuni and possibly other zoonotic pathogenic bacteria. 
Cui et al. 7 examined Campylobacter originating from 
conventionally and organically reared chickens in the USA 
and showed similar levels of resistance to tetracycline (78%), 
erythromycin (46%) and ciprofioxacin (8%). In contrast, a 
Belgian study showed lower levels of resistance in broiler and 
layer chickens, respectively, for: tetracycline, 34.4% and 20%; 
and erythromycin, 6.3% and 8.6%. The study also showed a 
higher level of ciprofioxacin resistance in their broiler and layer 
chickens: 44.2% and 27.6%, respectively.8 These fluctuations in 
resistance to common antibiotics differ from country to country 
and are reflective of local legislations that regulate the use of 
antimicrobials for animal prodUction. The termination or more 
efficient regulation of veterinary antibiotics resulting in 
decreased resistance in zoonotic bacteria has been reported by 
several studies globally.9 Unfortunately, South Africa has not 
taken any stance regarding the use of antibiotics in animal feed. 
The use of antibiotics, either sub-therapeutically or as growth 
promoters, in animal feeds is legislated under Act 36 of 1947 as 
Stock Remedies and is regulated by the Department of 
Agriculture. I 0 
Children are particularly vulnerable to campylobacterioses 
through zoonotic acquisition. Clinical Campylobacter isolates 
collected at the Red Cross Children's Hospital in Cape Town, 
South Africa, from the period 1998 to 2005 have shown a steady 
increase in resistance to antibiotics: resistance to ciprofloxacin 
increased from 1.4% to 29%; to erythromycin from 3.4% to 
7.2%; to nalidixic acid from 5.7% to 41%; and to ceftriaxone 
from 3.6% to 24.6%. For the first time, multiresistant 
Table 1. Percentage resistance and MICso and MIyO results for C. jejuni isolates collected from broiler and layer chickens in 
KwaZulu-Natal, South Africa 
% resistance MIC,o (mgIL) MIC,o (mgIL) 
Antibiotic broilers layers broilers layers P broilers layers P 
Ciprofioxacin 8.9 23.8 0.031 0.25 <0.(101 0.5 64 0.06 
Tetracycline 98.2 100 64 128 <0.001 128 128 NA 
Erythromycin 50 42.9 12 4 0.6 128 128 NA 
Ceftriaxone 96.4 100 32 32 0.9 128 64 NA 
Clarithromycin 55.4 76.2 16 64 0.3 128 128 NA 
Ampicillin 32.1 57.1 8 16 0.07 16 32 0.9 
Nalidixic acid 35.7 52.4 4 16 0.8 128 128 NA 
Gentamicin 1.8 19 I 2 <0.001 2 8 om 
NA, not applicable. 
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Campylobacter isolates were also observed in South Africa. ll 
Steady increases in fiuoroquinolone and macrolide resistance 
and increased penicillin resistance were also observed in the 
Venda district, South Africa, from 2002 to 2007; resistance to 
ciprofloxacin has increased from 8% to 13%, to erythromycin 
from 25% to 53%, and to gentamicin from 8% to 17.3%. 
However, fewer clinical isolates were resistant to tetracycline 
(27%) and ceftriaxone (7%), which showed very high resistance 
among both broiler and layer chickens in this study.12 The 
Venda district study did not specify the Campylobacter species, 
but it is accepted that the Campylobacter species mostly respon-
sible for acute diarrhoea in humans is C. jejuni. 
Unlike European surveillance programmes, such as DANMAP, 
the prevalence and antibiotic resistance of Campylobacter infec-
tions in South Africa are not monitored and no surveillance pro-
gramme exists.1 The importance of such bacteria is overshadowed 
by the existence of more severe diseases, for example, HIV infec-
tions, malaria, tuberculosis and salmonellosis. 
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ABSTRACT 
Campylobacter bacteria are important ioodbome pathogens that cause acute diarrheal illness, and infection is often 
associated with contaminated poultry. In a blind observational study, the prevalence and resistance profiles of thermophilic 
Campylobacler strains collected from different poultry production systems were tested against the clinically used antibiotics 
ciprofloxacin, tetracycline, erythromycin, gentamicin, and streptomycin. Campylobaeter strains were isolated from chickens in 
rural production systems, a free-range commercial facility, and industrially raised broiler and egg-laying chickens all situated in 
KwaZulu-Natal, South Africa. Isolates were collected from the chicken cecae and were identified with conventional methods and 
tested for antibiotic resistance with the Clinical and Laboratory Standards Institute agar dilution method. The prevalence of 
Campylohacter spp. isolates in chickens was 68% (56 samples) in ruml production, 47% (140 samples) in commercial free-range 
broilers, 47% (133 samples) in industrial broilers, and 94% (34 samples) in industrial layer hens. Isolates from the rumlly raised 
chickens showed significantly (P < O.OJ) less resistance against ciprofloxacin (7.9%), erythromycin (0%), and tetracycline 
(21.6%) than those from commercially produced chickens. lsolate~ from the commercially raised chickens (free range and 
industrial) were highly resistant to tetr-dl.'ycline (98.9 to 100%). The incidence of gentamicin and streptomycin resistance was 1.6 
and 11.5%, respectively, in commercial free-range broilers, 1.7 and 16.4%, respectively, in industrially mised broilers, and 12.9 
and 40%, respectively, in industrially raised layers. It is possible that variations among the poultry production systems, including 
antimicrobial usage, result in differences in antibiotic resistance profiles in Campylobacter. 
Bacterial stress in the gastrointestinal tract is caused by 
the therapeutic or prophylactic use of antibiotics during meat 
production, prompting the occurrence of antibiotic-resistant 
strains (19). Campylobacter jejuni subsp. jejuni and Cam-
pylobacter coli have both been identified as pathogens that 
frequently cause acute diarrhea in humans, especially in 
children and the elderly (15,30). Campylobacter infection 
acquired through the oral route has been shown to have a 
possible connection with the development of Guillain-Barre 
syndrome (18), and Campylobacter is the most frequently 
isolated bacterium that causes diarrhea in AIDS patients (17, 
25). The sources of these Campy[obac:ter infections are often 
linked to meat products and, in particular, to poultry products 
(21). Although the diarrhea caused by campylobacters is 
normally self-limiting, failure of the immune response results 
in the need for therapeutic intercession. The preferred frrst-
line antibiotics are macrolides and fluoroquinolones, and 
thus, concern has been expressed about the health risk to 
humans of antibiotic-resistant Campylobaeta strains associ-
ated with the use of antibiotics, often belonging to classes 
used for human therapeutic treatment, during meat and 
poultry production (10, 31 ). 
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In South Africa, the poultry industry accounts for 43% of 
the national total of animal-derived products (27). Commer-
cial poultry production is undertaken by industrialized and 
free-range fanning systems, and antibiotics are utilized both 
therapeutically and prophylactically. However, there is also a 
third fanning system widespread in suburban and rural 
KwaZulu~Natal and, indeed, throughout sub-Saharan Africa, 
where antibiotic usage is either limited or absent: namely, 
infonnal small-scale family fanning (henceforth referred to as 
rural production), in which indigenous poultry roam freely 
and scavenge for food themselves (8). 
South Africa has no public health or food production 
surveillance program for Campylobacter spp. The objective 
of the present study was to evaluate the frequency of 
isolation and the antibiotic resistance profiles in Campyla-
baeter isolates collected from each of the pOUltry production 
systems, namely, rural, commercial free-range broilers, 
industrialized broilers, and industrialized layers, in relation 
to the differing antibiotic sources and usage in each system. 
MATERIALS AND METHODS 
Ethical clearance was obtained from the University of 
KwaZulu-Natal Animal Ethics Sub-committee (OI5/07/Animal). 
Except for the ruml chickens, all samples were collected randomly 
from abattoirs during 2008 and 2009. No data on the specific 
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TABLE I. Prevalence of Campylobacter isolates collected from the different farming systems 
Fanning system No. of samples 
Rural chickens 56 
Commercial free-range broilers 140 
Induslrial broilers 133 
Industrial layers 34 
" Campy/obaeter spp. excluding C. jeiuni and C. coli. 
antimicrobials used on the fanus that supplied the abattoirs are 
available except what is known from commercial feed suppliers 
and legal usage. Antibiotics used in South African commercial 
poultry production as growth promoters and therapeutic treatment 
include tetracyclines (oxytetracycline and chlortetracycline) and 
macrolides (tylosin and kitamycin). Antibiotics indicated for 
therapeutic treatment only are beta-lactams (amoxycillin), quino-
lones (enrofloxacin and norlioxacin), and aminoglycosides (neo-
mycin and spectinomycin) (12, 28). A single large commercial 
free-range farm in KwaZulu-Natal province assisted with samples 
from an in-house abattoir for broiler chickens (5 to 8 weeks old). 
Samples from industrialized chickens, both broilers (5 to 8 weeks 
old) and layers (36 to 54 weeks old), were collected at four 
abattoirs situated in KwaZulu-Natal. Adult indigenous chickens 
were collected from rural communities in Port Shepstone, Mvoti, 
Maphumulo, and Shongweni, all in KwaZulu-Natal. Two adult 
chickens were collected from every third household in each 
locality. The birds were slaughtered at the Biomedical Resource 
Unit (a laboratory animal science unit in the University of 
KwaZulu-Natal), and samples collected from the cecae. 
Bacterial isolation and identification. The Cape Town 
protocol (14) was used for isolating Campylahacfer spp., but instead 
of isolating the organisms on antibiotic-free tryptose blood agar, a 
saline suspension of fecal matter collected from the ceca of each 
animal was passed through a 47 -mm cellulose nitrate filter of O.65-~m 
pore size (Sartorius Stedim Biotech, GmbH, Goettingen, Germany) 
onto a Butzler plate (Campylabacter-selective medium SR0085E, 
Oxoid, Ltd., Basingstoke, UK) and Campylahacte!" growth supple-
ment SR0232E (Oxoid) containing 5% lysed horse or sheep blood. 
Suspected Campylobaeter colonies were screened according to Gram 
staining and characteristic spiral morphology and further identified 
using biochemical testing based on indoxyl acetate hydrolysis, 
hippurdte hydrolysis, growth at 42 and 24°C, and sensitivity to 
nalidixic acid (30 ~g; Oxoid) and cephalothin (30 ~g; Oxoid). 
Antimicrobial susceptibility testing. Campylobaeter strains 
were stored in tryptose soy broth (Oxoid) supplemented with 10% 
glycerol (ACE Pty., Johannesburg, South Africa) at -6(}"C until tested 
for antimicrobial susceptibility. The WC (micrograms per milliliter) of 
an antibiotic required for total growth inhibition was determined by the 
agar dilution method of the Clinical and Laboratory Standards Institute 
(CLSI) (4). The susceptibility breakpoints of Enterobacteriaceae for 
ciprofloxacin (Fluka AG, Buchs, Switzerland), tetracycline (Sigma-
Aldrich Chemie GmbH, Steinheim, Gennany), and gentamicin (Sigma) 
(3) were used, together with the proposed CLSI guideline for 
susceptibility of Campyiobaeter spp. to erythromycin (Sigma) (2). 
Epidemiological cut-oft"values in survei!lance monitoring were used for 
streptomycin (Sigma) (9). Escherichia coli A TeC 25922 and 
Psewiomonas aeruginosa A TeC 27853 served as controls as described 
in the CLSI standard parameters for MIC susceptibility testing. C.jejuni 
ATCC 29428 served as a growth control. 
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% (no.) with isolates of: 
C. jejuni C. coli Campy/obaeter spp." 
29 (11) 71 (27) 
48 (32) 52 (34) 
70 (44) 25 (16) 5 (3) 
69 (22) 9 (3) 22 (7) 
Statistical analysis. Statistical validity was predetermined at 
95%. PailWise comparisons were made with Wilcoxon's rank sum 
test in cases where overall differences in the percentages of 
resistant thermophilic Campylabaeter spp. were significant. The 
Stata version 10 statistical package (Stata, Inc., College Station, 
TX) was used for data analysis. 
RESULTS 
Prevalence of Campylobacter in the different poul~ 
try production systems. There were 38 Campylabacter 
isolates collected from 56 samples from poultry at rural 
production facilities, 66 isolates from 140 samples from 
commercial free-range chickens, 63 isolates from 133 
samples from industrial broilers, and 32 isolates from 34 
samples fTOm industrial layer chickens. The frequency of 
thermophilic Campylobacrer spp. isolates in KwaZulu-Natal 
was 68% in poultry raised in rural fanning systems, 47% in 
commercial free-range broilers, 47% in industrial broilers, 
and 94% in industrial layers. The ratio of C. jejuni subsp. 
jejuni prevalence to C. coli prevalence varied between the 
production systems, with C. coli more prominent in the rural 
(7! %) and commercial free-range broiler (52%) groups, 
while C. jejuni subsp. jejuni was more dominant in the 
industrialized broiler (70%) and layer groups (69%) 
(Table I). 
Antibiotic susceptibility. The results show a relation-
ship between restricted antibiotic usage and the prevalence 
of Campylobacter antibiotic-resistant strains in pOUltry 
production. Compared to the other groups, the rural group 
showed the lowest occurrence of resistance (Table 2). 
Isolates from the commercial free-range broiler and 
industrial broiler and layer groups showed higher resistance 
to tetracycline (100, 98.9, and 100%, respectively). Except 
in the case of erythromycin, the industrial layer group 
(nonnally older birds, aged 36 to 52 weeks) showed more 
resistance than the industrial broilers (normally younger 
birds, aged 5 to 8 weeks), although the significance was not 
detennined. 
MICsos and MIC90s. The MICsos (MICs required to 
inhibit gTOwth by 50%) and MIC90s for the different 
production systems are described in Table 3. The rural 
production group's MICsos were low for ciprofloxacin 
(0.13 J-lg/ml), tetmcycline (0.125 J-lg/ml), erythromycin 
(0.125 Ilg/ml), gentamicin (0.25 J-lg/ml), and streptomycin 
(! J-lg/ml). The MICsos for commercial free-range chickens 
for ciprofloxacin (4 J-lg!ml), tetracycline (64 fIg/ml), and 
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TABLE 2. Frequencies of antibiotic resistance of Campylobacter isolates collected Fom the different farming systems 
No. and % of resistant isolates 
Commercial 
free-rmge Industrial 
Antibiotic RornJ broilers broilers Industrial layers 
a~, 
MIC breakpoint No. % No. % No. % No. % P values 
Ciprofloxacin 
Quinolones 
MIe::=;: 1 38 7.9 66 95.4 63 15.9 32 17.7 Rural vs commercial free-range broilers, P < 0.01; 
rural vs industrial broilers, P = 0.4; rural YS 
industrial layers, P = 0.3; commercial free-range 
broilers vs industrial broilers, P < 0.01 
Tetracycline 
Tetracyclines 
MIC::=;: 4 37 21.6 66 100 63 98.9 32 100 Rural vs commercial free-range broilers, P < 0.01; 
rural vs industrial broilers, P < 0.01; rura'! vs 
industrial layers, P < 0.0\; commercial free-
range broilers vs industrial broilers, P = 0.5 
Erythromycin 
Macrolides 
MIC:=:;; 8 38 0 66 87.9 63 47.6 32 43.7 Rural vs commercial free-range broilers, P < 0.01; 
rural vs industrial broilers, P < 0.01; rural vs 
industrial layers, P < 0.0]; commercial free-
range broilers vs industria! broilers, P = 0.04 
Gentamicin 
Aminoglycosides 
MIC:=:;;4 37 0 61 1.6 60 1.7 31 12.9 Rural vs commercial free-range broilers, P = 0.9; 
rural vs industrial broilers, P = 0.9; rural vs 
industrial layers, P = 0.04; commercial free-
range broil~ vs industrial broilers, P = 0.9 
StreptomycinO 
Aminoglycosides 
MIC ~ 2b 37 5.4 61 11.5 55 16.4 20 40 Rural vs commercial free-rdJlge broilers, P = 0.5; 
rural vs industrial broilers, P = 0.2; rural vs 
industrial layers, P < 0.01; commercial free-
range broilers vs industrial broilers, P = 0.6 
MIC:5 4' 0 8.2 12.7 25 Rural vs commercial free-range broilers, P = 0,2; 
rural vs industrial broilers, P = 0.04; rural vs 
industrial layers, P < 0.0 I; commercial free-
range broilers vs industrial broilers, P = 0.5 
a Due to the lack of a CLSJ breakpoint for streptomycin, the European Food Safety Authority cut-offs for C.jejuni subsp.jejuni and C. coli 
were used (9). 
h MIC for C. jejuni subsp. jejuni. 
C MIC for C. coli. 
erythromycin (64 ]lg/ml) were significantly higher (P < 
0.01) than those for poultry from the rural system. The 
MIC50 for industrialized broilers for tetracycline (64 ]lg/ml) 
was significantly higher (P < 0.01) than that in the rural 
poultry system (0.125 ]lg/ml). The MICso for industrial 
layers for tetracycline (128 flg/ml) was significantly higher 
than that for poultry in the rural system (P < 0.01). 
The MIC90s for ciprofloxacin in Campylobacter isolates 
from commercial free-range broilers (8 ]lg/ml), industrial 
broilers (16 ].lg/ml), and industrial layers (16 ]lg/ml) were 
significantly higher (P < 0.01) than those in Campylobacter 
isolates from poultry in the rural system (I )J.g/ml). The 
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MIC90s for tetracycline were consistently high (128 j.lg/ml) 
for all the poultry systems investigated. The MIC90s for 
erythromycin were significantly higher (P < 0.01) for 
commercial free-range broilers (128 flg/ml), industrial 
broilers (128 ]lg/ml), and industrial layers (128 ].lg/ml) than 
for poultry in the rural system (l ]lg/ml), The MICws for 
gentamicin were significantly higher in Campylobacter 
isolates from industrial layers (8 j.lg/rnl) than from poultry 
in the rural system (0.25 ]lg/ml). The MI~os for streptomy-
cin were significantly higher in Campylobacter isolates from 
industrial layers (20 ]lg/ml) than from poultry in the rural 
system (2 ]lg/ml). 
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Limitations of the study. Among the limitations of our 
study was its blind observational nature, since only one 
commercial free-range fann participated in the study. In 
addition, the prevalence of hippurate-negative C. jejuni 
subsp. jejuni isolates was not confirmed with molecular 
identification. It is probable that a small number of such 
isolates would have represented organisms mistakenly 
identified as C. coli or other hippurate-negative thermophilic 
Campylobacter spp. (24). 
Prevalence. Woodward et al. (32) found that humans 
and a variety of animals, including wild birds, rodents, pigs, 
and cattle, can spread contamination of Campylobaeter spp. 
In the present study, poultry in rural fanning systems are 
often only confined to a holding area in the evenings and 
have interaction with other animals, for example, cattle, 













Rura! vs commercial free-range broilers, P < 0.01; 
rural vs industrial broilers, P < 0.01; rural vs 
industrial layers, P < 0.01; commercial free-
range broilers vs industrial broilers, P < 0.01 
Rural significantly lower than free-range broilers 
and industrial broilers and layers, P < 0.001 
Rural vs commercial free-range broilers, P < 0.01; 
rural vs industrial broilers, P < 0.01; rural vs 
industrial layers, P < 0.01; commercial free-
range broilers vs industrial broilers, P = 0.5 
No difference in MICgoS, P = 0.06 
Rura! vs commercial free-range broilers, P < 0.01; 
rural vs industrial broilers, P < 0.D1; rural vs 
industrial layers, P < 0.01; commercial free-
range broilers vs industrial broilers, P < 0.01 
Rural significantly lower than free-range broilers 
and industria! broileD> and layers, P < 0.001 
Rural vs commercial free-range broilers, P = 0.2; 
rural vs industrial broilers, P < 0.01; rural vs 
industrial layers, P < 0.01; commercial free-
range broilers vs industrial broilers, P < om 
Rural significantly lower than industrial broilers 
and layers, P < 0.001; free-range broilers 
significantly lower than industrial broilers, 
P < 0.001 
Rural vs commercial free-range broilers, P = 0.2; 
rural vs industrial broilers, P < 0.01; rural vs 
industrial layers, P = 0.3; commercial free-
rdllge broilers vs industrial broilers, P < 0.01 
All MIC9{ls significantly different, P < 0.008 
sheep and rodents, in the areas they scavenge freely for food 
sources (8). In a Tanzanian study, thermophiliC Campylo-
bacrer spp. were isolated from rural chickens significantly 
more often than from commercial broiler chickens (76 
versus 60%, P < 0.01) (20), in a percentage comparable to 
the 68% prevalence of thennophilic Campylobacter spp. 
isolated from rurally raised poultry in the present study. 
The mtio of the prevalence of C. jejuni suhsp. jejuni 
isolates to that of C. coli isolates in the different fanning 
systems suggested that C. coli dominated in the rural and 
commercial free-range broilers. However, this study is only 
observational and, thus, further investigations will be 
needed to clarify this dominance. Most other studies (J 1 , 
13) have found C. jejuni subsp. jejuni to be typically the 
predominant species in poultry, as was found in the 
industrialized broiler and layer groups in this study. Corry 
and Atabay (5), in a study of reports from The Netherlands 
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and Northern Ireland, found that the prevalence of C. coli 
can often equal that of C. jejuni subsp. jejuni in live 
chickens and carcasses. 
Resistance. In South Africa, the Department of 
Agriculture regulates the usage of antibiotics, prophylacti-
cally or as growth promoters, under the Stock Remedies Act 
No. 36 of 1947 (7). Antibiotics for agricultural usage in 
South Africa are more freely available than in. for example. 
the United Kingdom, where growth-promoting antibiotics 
can only be obtained by prescription (26). In rural settings, 
87% of the family poultry systems studied in KwaZulu-
Natal used traditional remedies originating mostly from 
plant material. In addition. the use of commercial products, 
and in particular, "Terramycin" and potassium pennanga-
nate, has also been reported (8). The ciprofloxacin resistance 
found in the commercial production systems can be 
attributed to the use in these fanning systems of enroflox-
acin and norfloxacin. It has been reported that the use of 
enrofloxacin in poultry production (broilers) dramatically 
increased the resistance of C. jejuni subsp. jejuni isolates to 
ciprofloxacin (22), nalidixic acid, and ofloxacin (29). 
Large amounts of tetracycline are used in the South 
African animal production system. A recent study in the 
Gauteng and Western Cape provinces of South Africa also 
reported high resistance of Campylobacter isolates from 
broiler poultry against tetracycline (95%), doxycycline 
(60%), and chlortetracycline (70%) (12). The present study 
found that all the highly (>64 fig/ml) tetracycline-resistant 
isolates among the rural group were identified as C. jejuni 
subsp. jejuni. It is uncertain whether this was by coincidence 
and whether it has something to do with the expression of the 
tet(O) gene in C.jejuni subsp.jejuni and C. coli: tetracycline-
resistant C. coli expresses the tet(O) gene al a chromosomal 
site, while the tetracycline-resistant C. jejuni subsp. jejuni 
expresses the gene on a conjugative plasmid (6). 
In a study (in this case a human study) by Putnam et a1. 
(23), Campylobacter isolates were obtained from stool samples 
collected from young children in a rural fanning district of 
Egypt from ] 995 to 2000. The study found low antibacterial 
resistance linked to an absence of antibiotic exposure; the 
isolates showed no resistance to the macrolides erythromycin 
and azithromycin and low resistance to ciprofloxacin, although 
this was observed to have increased from 17% in 1995 to 58% 
in 2000 (23). At the time of the Putnam et al. study, 
fluoroquinolones were not indicated for pediatric treatment in 
the locality of the study but they were used in other community 
health contexts, and norfloxacin was used in food animal 
production. The investigators suggested that the increased 
antibiotic resistance of Campylobacter isolates from 1995 to 
2000 may have come from exposure of the children to an 
antibiotic-resistant gene pool (23). 
The use of the macrolides tylosin and kitamycin in 
commercially produced free-range and industrialized poul-
try was reflected in the erythromycin resistance of C. jejuni 
subsp. jejuni and C. coli isolates encountered in our study. 
Lin et al. (16) noted that a single dose of tylosin given to a 
poultry flock had little effect on selection for erythromycin 
resistance in Campy!obacrer and that multiple exposures, 
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typically the case when tylosin is used as a growth-
promoting agent, were needed to establish erythromycin-
resistant strains. Conversely, one would not expect to find 
resistance in rurally reared chickens. 
This study is an expansion on the limitations of a 
previous study by Bester and Essack in 2008 entitled 
"Prevalence of antibiotic resistance in Campylobacter 
isolates from commercial poultry suppliers in KwaZulu-
Natal, South Africa" (1). The results of the present study 
highlight the prevalence of aminoglycoside resistance in 
commercially bred poultry. 
In conclusion, the prevalence of Campylobacter 
isolates was higher in the rural and industrial layer chickens 
than in the industrial broilers and commercial free-range 
broilers, although study limitations do not permit extrapo-
lation of the results as representative of the different poultry 
production systems. The study showed that when compar-
ison is made between chickens from commercial production 
systems and rurally reared chickens, there is an association 
between lower antibiotic usage (in the rurally reared 
chickens) and reduced incidence of antibiotic-resistant 
Campylobacter isolates. The rurally reared chickens showed 
the lowest incidence of resistant Campylobacter isolates; the 
commercial free-range broiler and industrial broiler and 
layer groups showed high levels of tetracycline-resistant 
Campylobacter isolates, most likely attributable to on~going 
high levels of tetracycline use in commercial animal 
production systems, specifically, poultry production sys-
tems, in South Africa. The fact that antibiotic-resistant 
Campylobacter strains were also recovered from the rurally 
reared chickens is an indication that sources of antibiotic-
resistant Campylobacfer exist other than the development of 
resistance following therapeutic or prophylactic antibiotic 
treatments in animal production. A t~\ctor to consider in this 
regard is that the levels of hygiene are often lower in rural 
communities, heightening the incidence of common illness-
es, and with the added prevalence of HIV IAIDS and 
tuberculosis, there is a likelihood of long- and short-teffi1 
antibiotic use and abuse in the public health sector. The 
study also indicated that differing poultry production 
systems and antimicrobial progmms can generate unique 
antibiotic resistance profiles. 
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Synopsis 
Objectives: The objective ofthe study was to delineate the similarities/difference (if any) in 
'lhe antibiograms, plasmid profiles and strain types of Campylabaeter spp. from different 
potiIttyJarming systems in KwaZulu-Natal, South Africa. The study additionally compared 
phenol)'pi.~;"hd genotypic identification methods of Campylobacter against the gold standard 
of pOly;e#~.J~1ain reaction (PCR) in terms of sensitivity, specificity, positive-predictive 
32 value and neJij~~-J!Jedictive value. Methods: Thermophilic Campylabacter isolates was 
.£0y.#0'" 
33 identified using co 1 biochemical tests, specifically hippurate hydrolysis, MALDI-
'fP 
34 CR with primers unique to C. jejuni and C coli. Plasmid 
35 analysis was undertaken u i)l!kaline lysis method and PFGE was executed according to 
36 
i#y ,·~e 
the Pulse Net protocol described for J:i!!f!pylobaeter bacteria. Results: The MALDI-TOF was 
-"""/ ' <'£iP 
37 shown to be superior to the biochemi s for the identification of C coli but equivalent to 
38 the biochemical tests for C jejuni. Plas ds were harboured in 84 % (16/19) of the isolates 
39 from the free-range broilers, 83 % (10/12) industrial layers, 72 % (18/25) of 
40 the isolates from industrial broilers, and 77 % f isolates collected from rural or 
41 informally reared poultry. The PFGE genotyping of 4 labacter isolates generated 39 
42 Sma! types (47.6 % in C coli, 33.3 % in C jejuni and 2.4 ~~l1.[ari) of which 28 % were 
43 amongst industrial broilers, 26 % amongst the free-range bf()ile~'!!!(jp% amongst industrial 
44 layers, and 21 % amongst rural or informally reared poultry. 
45 any of the parameters within and between farming systems attesting ,piversity and 
46 complexity of phenotypes and genotypes and indicating de novo evoluti&h.iQ·.;'llntibiotic 
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51 Introduction 
52 ~everal studies have reported on the host specificity of Campylabacter spp. with strains of 
53 "iu\:Unals and humans found to be less adapted for colonization and infection outside their 
54 origilial.. hosts. 1. 2 Although anUnal-derived strains often show very little similarity to 
55 clinical;'~trl;lihs, researchers are still finding it difficult to confirm campylobacter species as 
56 those of aUrtl~' .origin because of the high genetic variations. 3 Thakur et al. (2009) 
57 suggested thaLf?ti~~iq,~nifold methods of food animal production selects for "ecologically fit 
58 
59 
oji using pulse-field-gel-electrophoreses (PFGE) and multi-locus 
"0" 
is4 Fitzgerald et al. (2001) indicated that the survival or 
60 dominancy of a Campylab .!\lin lies is in its ability to genomically adapt by rearranging 
61 its genome, 3 while Taboada et reported in a study using microarray genomic 





random, but restricted to certain the. genome leaving a large portion stable.5 
However, genetic diversity may be higher i~!~lotion systems where there is exposure to a 
=J%:!7 , 1€> 
variety of environmental sources contaminated wiL~~p.Ylobacter. 6 
m= 
67 The study compared Campylobacter spp. isolated from differ.@~rming systems in terms of 
"1'" 
68 antibiograms, strain typing and plasmid analysis. Secondarily it ~f!lfll~,d the phenotypic and 







desorption ionization- time of flight (MALDI-TOF) mass spectrometry t~1~~'J?,0Id standard 
of polymerase chain reaction (peR) method in terms of sensitivity, speclffc~!¥,..positive-
.'/ 
predictive value and negative-predictive value. 
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76 Materials and methods 
77'rs;ampylobacter strains 
78'~ total of 69 isolates obtained from three different farming systems were used, viz., 13 
79 isorafe~from rural or informal farms, 19 from a free-range system and 37 from an industrial 
80 farm\ng'~~!it~ln, the latter further stratified into industrial broilers (25 isolates) and industrial 
"" ' \~ 
81 layers (l2'1i:sQI~fe'~). These isolates were screened as thermophilic Campylobacter using the 
82 conventional ~,it1iiJ~ including Gram staining for unique spiral morphology, growth at 
83 . ~phalothin disc susceptibility and hippurate hydrolysis. C. jejuni 
'!if' 
84 spp. jejuni is positive negative for the hippurate hydrolysis tests. 
85 
86 Antibiotic Susceptibility MIC's 
87 The minimum inhibitory concentra C) were done using the CLSI agar dilution 
88 
89 
method 7 as described previously 8 0 an antibiotic panel consisting of tetracycline, 
ciprofloxacin, erythromycin, gentamicin an"~l'l.mYCin. Escherichia coli ATCC 25922 
~"J*FRfl 
90 and Pseudomonas aeruginosa ATCC 27853 were ~s~~ 
91 
92 PCR 
93 PCR identification of Campylobacter was conducted accordin 
94 DNA extraction was accomplished using the heat-lysis method .. samples were 
95 quantified spectrophotometrically using the NanoDrop 2000 (Therrit~S~"ptific, South 
96 Africa) and standardised to 15 ng/JlI with nuclease free water. For the iderlfillt<t!ion of C. 
'I"" 
97 jejuni, the region of the hippurate gene (HipO) consisting of 735 base pairs was usea:'The 
98 primer pairs used were: forward 5'-GAA GAG GGT TTG GGT GGT-3' and reverse 5'·~GC 
99 TAG CTT CGC ATA ATA ACT TG-3' 9. For C. coli identification a region of the putative 
100 aspartokinase gene was used with an amplicon of 500 base pairs. The primer pairs used were: 
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101 forward 5'-GGT ATG ATT TCT ACA AAG CGA G-3' and reverse 5'-ATA AAA GAC 
102 'TAT CGT CGC GTG-3' 9, The primers were commercially synthesized by Inqaba 
103Blt,ltechnicallndustries (Pty) Ltd. (Joharmesburg, South Africa), 
104 
105 The l'!!!R~."lttion volume for each sample was 40111, comprising of: GoTaq® Flexi Buffer, 
,,00'"'" 
106 1.5mM Mi::~l~OIlM of each dNTl', 0,5 U GoTaq®DNA polymerase (l'romega), and 45ng 
<3:;' 
107 genomic DN,..(~1l\'R~~te. For the HipO (735) 30 pmol of forward and reverse primers was 
108 used and for the p partokinase (500) 10 pmol of forward and reverse primers were 
'7' 
109 ification conditions were as follows: initial denaturation (95 
110°C, 5 min), followed by 35 s41l'f denaturation (95°C, 30 sec), annealing (58 °C, 30 sec) 
111 and extension (12 °C, 30 sec). Final "~~"sion was achieved at 12°C for 5 minutes using the 
'f(~"~ ~ 
112 Chrom04 DNA Engine Thermocyc1e South Africa), 
113 
114 MALDI-TOF analysis 
115 The isolates were identified using i!' spectrometry (Autoflex, Bruker 
116 Daltonics) by the direct application method, Using a ,~~1ah applicator a small quantity of 
117 colonies of 24 - 48 hr cultures from a micro-aerophilic a!@g~phere were smeared on a 
'9-' 
118 microtitre spot of a 384 polished steel plate (Bruker Daltonics, H~!~JllleJ!, Germany), This was 
119 overlayed with 1 IlL matrix which is a saturated cyano-4-hydrox 
120 (HCCA) (Bruker Daltonics, Bremen, Germay) and allowed to dry. Calibr 
acid solution 
U'~"s done with 
121 the Bruker Daltonics bacteria test standard (BTS) which is an E coli contrJ1T~jJle. Each 
122 isolate was executed in duplicate and set in linear mode with the parameters set at mass'ril,nge 
123 0[2 -20 kDa, lSI 20 kV, lSI 18,62 kV, lens 6.5 kV. Spectra were analysed using the MALDJ· 
124 Biotyper 3.0 software (Bruker Daltonics, Germany) and the Bruker Genotypic database was 
125 selected for the identification framework. The peaks generated were automatically compared 
Journal of Antimicrobial C"emlolllerap'l: under review 
Journal of Antimicrobial Chemotherapy 
126 to the data in the genotypic data base and its probability conveyed to a score. The range of 
127 S.cores and descriptions were analysed as follows: 2.300 to 3.000 are highly probable species 
128 . ide.ntification; 2.000 to 2.299 are a secure genus identification and probable species 
129 idenlifj5ation; 1.700 to 1.999 are probable genus identification; and 0.000 to 1.699 are not a 












~g the alkaline lysis method (GeneJET Plasmid Miniprep kit, 
o the manufacturer's plasmid purification protocol using the 
ljPlied in the kit. The purified plasmid DNA was stored at 
-20°C until electrophoretic anai~sis .. 0.~agarose gel (I %) was made with 0.5 x Tris-borate-
~'·7 
'qy' "~ 
EDTA buffer (TBE buffer) (Fluk~1:Ii~hemika, Sigma-Aldrich Chemie, Buchs). The 
'-iR~~_r~, 
markers used were an E. coli NCTC 501<l~ strain with plasmid sizes 154 kb, 66.1 kb, 37.6 kb 
and 7.7 kb and a 1 kb DNA ladder (The ·~c O'GeneRuler, Lithuania). Following 
dj cl 
ethidium bromide staining plasmids were visualis~d~· UV light in a Bio Imaging System 
f 
141 (Chemi Genius2 Syngene). UVIgeltec.Iuk (Jencons-P ;) 'image acquisition software' 





Pulse-field gel electrophoreses (pFGE) 
PFGE were performed using the guidelines of the Pulse Net protocol 10 pl~~gf \!fere prepared 
from cultures that were incubated overnight on trypticase blood agar suppleJ~;£¢,·with 5% 
147 lysed sheep blood. Plugs were transferred to 5 ml lysis solution which is m'"bjjffer 
148 containing I % sodium N-Iauroylsarcosine (Fluka BioChemika, Sigma-Aldrich Cheini", 
149 Buchs) and 25 III of the proteinase K (20 mg/ml proteinase K, Thermo Scientific, Lithuaniaf 
150 After 2 hrs of agitation plugs were rinsed with 3 washes of TE buffer and stored at 4 °C until 
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151 analysis. Small slices of plug were treated willi 2.5 fll SmaI (Thermo Scientific FastDigest, 
1~2 Lithuania) restriction enzyme for 2 hrs. Plugs were loaded in a gel prepared with 1 % agarose 
153 (for PFGE, Sigma-Aldrich, St Louis, USA) in 0.5 x TBE buffer together with a lambda 
154 la\tClet"{CHEF DNA size standard, Bio-Rad laboratories, Inc. USA) and C. jejuni ATCC 
155 sitive control to evaluate llie enzyme activity. Gels were electrophoresed in 
156 on a Bio-Rad CHEF MAPPER 1M with the following auto algorithm setting: 
157 low set at 50 kb and high molecular weight set at 500 kb; calibration factor 
158 1.00; gradient 6.0 "g,time 19 hrs, included angle 120°, initial switch time 6.75 s, final 
\0 
159 switch time 38.35 s an factor linear. Agarose gels were stained in ethidium bromide 
160 solution (Fluka BioChemi -Aldrich Chemie, Buchs) and visualised using UV light 
161 in a Bio Imaging System (Chemi Syngene). Dendogram analysis was perfonned by 
162 Bionumerics software version 6.6 ( Mallis NV, Belgium). The similarities using the 
163 band locations between llie isolates were alculated using the Dice correlation coefficient set 
164 at 1 % tolerance. 
165 
166 Results 
167 The results of llie identification, minimum inhibitory trl!limll's, plasmid profiles and 
168 strain types, are depicted for each of the farming systems in 
169 
170 Identification and specificity 
171 The sensitivity, specificity, positive predictive value and negative predictive0value of llie 
172 hippurate and MALDl-TOF mass spectrometry were compared with PCR methods flS the 
173 gold standard for the identification of C. coli and C. jejuni bacteria as shown in Table 5. Of 
174 the 68 isolates in llie study 26 were identified as C. jejuni and 38 as C. coli willi a single 
175 isolate identified as C. fari. The MALDI-TOF mass spectrometry was shown to be superior to 
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176 the biochemical tests for the identification of C coli but equivalent to the biochemical tests 
1T/"ror C jejuni. 
178!J'';bl~5: Comparison of hippurate and MALDI tests to the gold standard (PCR) for 
179 sensit:il71ty,,~pecificity, positive predictive and negative predictive values 
, "c', 
180 
Test Sensitivity Positive predictive Negative predictive 
100% 86.7% 90.5 % 100% 
Hippurate (C j 100% 100 % 97.6% 
MALDI"TOF (C c 96.7% 97.4 % 100% 
MALDI-TOF (Cje' 100 % 100% 97.6% 
181 
182 
183 Plasmid profiles 
184 The molecular weights of plasm ids 9 isolates from free-range broilers ranged from 
185 - 163 kb to - 57 kb and were harboured in % (16 isolates) of the isolates. Of the 25 
186 isolates from the industrial broilers 77.3 % ) was found to harbour plasmids with 
187 molecular weight ranging from - 170 kb to < 7.7 e industrial layer hens evidenced 
188 plasmids in 12 isolates ranging in size from from - 293 7.7 kb in 83.3 % (10 isolates) 
189 of the isolates. A plasmid range of -210 kb to -39 kb was 75 % (9 isolates) of the 
190 isolates from the rural farming system. Collectively plasmids we 
191 isolates) of the C. coli isolates and in 80 % (20/25 isolates) of the C ,~J!·i1ms. Images of 
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201 Figure 1: Images of the plasmid profiles of the isolates from the 3 
202 (C) were images from the industrial broilers and layer hens respec 
203 broilers and (D) rural chickens. Lane I is the I kb ladder, and lane 2 the 





Journal of Antimicrobial Cr.enr."ltl1eral~lI: under review 
Journal of Antimicrobial Chemotherapy Page 10 of 23 
209 Pulse-field gel electrophoreses 
210Ihe PFGE genotyping of 42 Campylobacter isolates generated 39 Sma! types (Figure 2). Of 
211· 20 (47.6 %) were C coli, 14 (33.3 %) Cjejuni and 1(2.4 %) C. lari isolate. Substantial 
212 an~r~lif.l;;tantive genetic diversity was observed between and within fanning systems although 
213 variou~tl~tets of -70 % similarity were seen within fanning systems for both industrial and 
0iP'''' 
214 free-range0~;~1"'¥~. Just 3 identical isolates were identified amongst the 3 C jejuni isolates 
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PFGE CampytobaCter " 
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Indl1strial broHe:r$ R~SS 
Free-T8nse broilers RRRSS. 2: 
Ftee-range .broilers: RRR 0 
-coli CtA9-2 Free-range broilers RRRSS :2 
roll CIA 130' F't~~tange broilers RRRSS 2-
C. coli GlA75 Free·rtm.ge broilers RRSSS- ,Z 
'COli CIA itS: Ft:ee-f9I1ge- broilers RRRRR 2 
¢OJ, ,C1A13 Free~ral1gebr!lHers MIlSS 2-
~lj % f!l~j2) Fi;ee;'raDge broilers RRRSS- 0 
cOli CA24 Industria:! bro:VeTS RSSS-S 0 
C, cbli CA77 Industrial brolters ~SRSS $. 
C-. coli., CfA1-8 Fr.ee,..tailge,bfQllers RRRSS 2 
C, coli CA 1$0 tndustrta~ layers- RRRSS '1 
C. jejl!l1i PS3Of1 :Rurat SSSSS' .0 
jelurn 1I!V15 RUrilI SSSSS 
jOjUnI PS2312 Runal RM 2 
~Ii btt\46 ffa~i:E!i1g~ tii-JlfetS- ~RRSS 2 





! ndustTlai layers 
Runal 
Rtital 
c. jejuni PS1212 Rt\ral 
c. jej~(ni CA 173 lnous(r\a:llayers 
t. i~JUnj CA 1 o~ ',ndu'strial br-Oflers 
c.. Jejuni CA182 Industrial layefS 
















je;ool CA 137 
fajun! CA155 
jejuni CIA 77 
jejunl GA 169 





Industrial broif~rs RSRSS 
fncJustriaf layers RRRSS 
Fre-e-range broflers RRSSS 
Inqustrial layers 
j~junj PS15/1 Rural 
C. jejuni PS28/3 Rural 





220 Figure 2: PFGE Smal genotypic types generated from isolates from different farming systems. The R 
221 and S indicate resistance or susceptibility respectively for tetracycline, ciprofloxacin, erythromycin, 
222 gentamicin and streptomycin (in 4 cases the isolates were not tested for gentamicin and streptomycin). 
223 The numeric values in the last column indicate the number of plasmids. 
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224 Discussion 
225 '$,ensitivity of identification methods 








":~~:aayristics of bacterial species. Together with a dichotomous key tree the results of a series of 
bi~Ch~~Jit:'i~ts can distinguish between bacteria even if they are closely related. These are similarly 
rpylobacter 11. However, within species a percentage of natural ~exception to the 
rule' may eXIISI!,>~UJD together with technical errors in the laboratory the identification of a bacterial 
concluded, The hippurate hydrolysis test is traditionally used to distinguish 
,tt is subject to inaccuracy if the laboratory execution was not optimal. 
234 thus be incorrectly dermed as 
-negative C. jejuni species is well documented 13·15 and could 
db7i species, This was found with a single isolate from the 
235 rural farming system that was ide a hippurate negative C jejuni, but without peR 
236 would have been incorrectly identifi coli isolate. The polymerase-ehain-reaction 
237 (PCR) is a molecular based identification tool that £ . ses on a complete or partial gene that is unique 
238 for the bacterial species. PCR identification ,'rJl"'ltylobacter remains the gold standard 
ill ~"h,,,,,¥ 
239 despite the methodology being time-consum;~~i:" !!p~! labour intensive and despite 
~illli:'%$ 'Ab 
240 standardisation difficulties because of very different pri~f§'lffid peR target genes have been 
",gi~ 
241 published to optimise peR identification for Campylobacte",!iJI"'"" 'n the case of this study 
242 the PCR primers chosen were very specific for either C jejum 
243 species. This was highlighted when testing isolate CA 160 with resul ing that it was 
244 neither C jejuni nor C coli. This isolate was found to be 99 % related t"'"'th~ A TCC 
245 35221 strain when using primers that target the l6S ribosomal RNA gene, 
246 
247 Although the MALDl-TOF mass spectrometry apparatus is locally available albeit at Ii verY· 
248 high price it has the ability to identify pure bacteria culture within a relatively short time (less 
249 than an hour). This can be done directly without any biochemical testing. It is less labour 
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250 intensive especially when opting to use the direct method (indirect method also available) and 
2si 'ipuch less sample preparation is needed. In principle the MALDI-TOF mass spectrometry 
252 ;'use5 a "sof!" ionization technique by irradiating the crystalline structure of a prepared sample 
253 rem/Ul't\ in the production of gas-phase ions. The ions accelerate through an electric field that 
254 is detecfe.\l:J~il measured by calculating the "time-of-flight" (TOF), smaller molecules travel 
255 molecules take longer resulting in a spectrum compiled from the masses 
256 created is compared to an existing data base of which the relatedness 
257 is produced as a score. 17, 18 Bessede et al. (2011) compared the identification 
+7, 
258 PCR methods where it was shown to be 100% comparable 
259 with most thermophylic c ,llf'ters showing only a 0.6 % error on C. jejuni. 19 Here the 
260 indirect method has shown to be 1O~,*accurate and could be used as an alternative. The ,rv' 
261 indirect method is an extraction meth ere the cell suspension is pre-treated with ethanol 
262 followed by formic acid and acetonitrile atment to disrupt the cell walls. The supernatant is 
"~ 
then dispensed on the polished steel spot. Ajj'i:t~i et aI., (20 I 0) have been able to achieve a 263 
264 100 % accuracy using the indirect method. 20 Den peak analysis were also accurately 
265 achieved when compared to PCR analysis using main rojection (MSP) and principle 
266 component analysis (PCA) software 21, but the addition of t!l!:!~~il)ftware can become labour 
'0'. 
267 intensive and the MALDI-TOF is largely reserved as a resea 
268 diagnostic tool. If the MALDI-TOF mass spectrometry is going to 
269 methods as an identification tool it might be worthwhile for the Bruker 1'.l~ltt,!jlik agency to 
270 continually update the Bruker Genotypic reference data base as new Campyl&~~er species 
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275 Plasmids 
2],6" ""'Plasmids were present in isolates from all of the farming systems investigated in this study. 
277 "Although the sample size in this study was small it was noted that the isolates from the rural 
278 chicke~s harboured the least plasmids (75 % of the isolates). The prevalence of plasmid in the 
279 other :ta¥'!l!!lg systems, free-range hroilers, industrial broilers and industrial layer hens were 
280 84.2 %, 83.3 % respectively. The frequency of C. coli (75 %) isolates harbouring 
281 
282 
.~1' be less than the C. jejuni (80 %) isolates. This is similar to a study by 
"~ suggested that the incident of plasmids harboured by C. coli is 





a~ids with the highest frequency, 80 %, found in C. lari 
isolates. Of importance was t~e vadL~lln of the plasmid profiles noted between farming 
it?~5 ,1J~~ 
systems. In industrial productions larg~ numbers of birds are huddled together. These animals 
<~~ttg, 
are not exposed to the outside environmi-mt as. free-range or rural farming systems. It is 
¥~:J;q 
288 suspected that in this environment genetic transfonnation and plasmid exchange 
289 take place more rapidly as would be found in the 0 ing systems. Stress factors clearly 
290 playa huge role in each of these faming systems and i " the health and ultimately how 
291 both commensal and pathogenic organisms in the gastro-int~~Mal tract would react for the 
"~; 
292 sake of survival. Increased transfonnation was also found to with Campylobacter 
293 spp. that supports the theory of a "specific recognition sequence" w n originates from 
294 the same specie or related species. 23 
295 
296 Pulse-field-gel-electrophoreses 
297 The diversity of the Campylobacter genotypes is well-documented30• 31 and supported in 'fhjs 
298 study. Genotypic diversity was evident for both C. jejuni and C. coli isolates within and" 
299 between farming systems although some degree of homogenousity is applicable to isolates 
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300 from similar farming systems. It was also clear that C. jejuni, C. eoli and C. lari are 
3W" 0'tpnetically diverse although C. eoli and C. jejuni are more closely related. It was not possible 
302' ;'W4relate the genotypes to specific farming systems where growth promotor antibiotics were 















ate clusters to specific production farms. 31 Anderson et al. (20 II) found that 
systems where the poultry have more environmental exposure increases the 
eter genotypes, because of the multiple sources of contamination the 
hus both free-range and rural farming systems have the ability to 
'8l? 
pective of the presence or absence of antibiotics. 
The identification of Campylobaeter is challenging given that current PCR methods 
4li. 
are not standardised. However, MALDl-~;;-;ectrometry is a possible alternative diagnostic 
tool. The variety of plasmid sizes found . different farming systems indicate that 
'~ 
Campylobaeter have the ability to carry and exch\~~ etic elements that would be more 
.,J~ 
prevalent during antibiotic stress. The lack of correlati6" gst the parameters within and 
between farming systems attested to the diversity and co~jexity of phenotypes and 
"*" 
317 genotypes and indicating de novo evolution in response to anti~\!Jt!lioj:?election pressure and 
318 animal husbandry practices. 
319 
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462 Table I: Isolates from tbe free-range broilers showing tbe 3 identification methods, plasmid profiles 












~ F C. coli 
A, 2.106 
































,g;c. coli 2 156.197 
4. . 64.044 
CIA 18 neg 
C. coli 
2.348 
rArI/!'fJ, 2 149.479 
.If"v" 'Wi 69.584 
MICmg/L 
lET CIP ERY 
128 4 64 
64 4 64 
256 64 2 
32 4 128 
64 4 64 
32 4 64 









CIA 46 neg 
C. coli 
2.232 c.~~'~~~~2 _____ ~~~5~.:~:~~-+ __ 6_4 ______ 4 ______ 1_2_8 ____ 0_.2_5 ______ 1__ ~ 
CIA 130 neg 


















128 0.25 0.5 
256 8 64 
64 0.125 1 C. coli C. coli 2' l:g":.~,'l~.~OO I 32 
2.346 '\66·1 
~--------------------~ C. jejuni C ... 0 __ _ ,256 
2.281 . jejum _"'"' 32 2 0.25 2 
C. coli 147 716~r;;pp'l'j 
C. coli 2 ,,~R 
2.317 n.785 :" : 
4 64 0.25 2 
128 0.25 0.5 
r-C_I_A_4_1~ ___ n_e_g ____ ~~2_C_~C_9~_h_· ____ C_._C_O_Ii-t ___ 2 ______ ~_~_744_·7_~ _ r-_3_2 ___ ~ __ ~4=.~--~--,~!:-:;~6-4-----0-'-12-5-----1---1 
Enterococcus ~ 
feacaNs 128 
CIA 30 pos 2.236 C.jejuni 1 92.74 0.5 64 
CIA48 pos 
CIA08 neg 
CIA 122 neg 








C. coli o 
C. coli o 
72.215 256 64 :Q,i, ", ,'. 
64 4 64 
32 4 32 a:25,' 1 
...... 
466 HIP hippurate test; TET tetracycline; CIP clprofloxacm; ERY erythromycm; GEN gentamicin; STR 
467 streptomycin 
468 
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469 Table 2: Isolates from the industrial broilers showing the 3 identification methods, plasmid profiles 
andMIC's. 
Identification Plasmid analysis MICmg/L 
Number 
MWof 
MALDI-TOF PCR of 
bands 
TET CIP ERV GEN STR 
bands 
91.901 
C. coli 35.562 














C. jejuni 38.959 








C. coli 1 64 0.031 32 0.25 2 neg 
2.279 
1~5.22:il 
C. coli 82.<tAS 
CA85 neg C. coli 
~"s",,--









C. coli 1 66.1 0.25 1 neg 
2.335 
150.332 
C. jejuni 91.901 








C. coli 0 32 0.007 16 0.25 neg 
2.315 
CA 106 pos 
C.jejuni 
2.358 
C. jejuni 1 46.963 128 32 128 8 !1' 
Bacillus not 
CA21 neg circulans C.jejuni 1 84.245 32 0.031 0.125 0.5 2 
1.717 Ie. coli 
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CA 137 pas 
CA84 neg 
CA40 neg 






















































0.031 16 0.25 
0.125 0.125 0.5 
0.007 16 0.25 
0.25 128 2 
0.G15 16 0.25 
0.062 0.125 0.5 
0.031 32 0.25 
0.062 0.125 0.25 
0.5 128 2 
16 4 0.5 
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profiles and MIC's. 
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Table 4: Isolates from the rural chickens showing the 3 identification methods, plasmid 
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7. Antibiotic resistance in CaiIJPylobacter. isola.tes from poultry in· 
.. KwaZulu-Natal 
LA, Bester. SY Essac~ 
I~trodn~tion 
Hiimahi;' _ate: ___ expose~- to-__ :_Campylo_~£Jcter spp' thtorig;li 
pat}iw:ays tillit.jnclude." animils, __ -:fo()d~ and-the- envrr0Dnlent. 
The .use· of antibiotics; as '-gro~_pro~oters hy.commercial: 
.food. aJ:riirial:'prOducers-has-llie-.ability to select fOT.l)acteria 
-IeE>istaIlt t?antibiotics; The ~ ofiltissttidywas tO,determine 
. antibiotic sensi~vi1;y:pro:files of C(!nipji?ob~cte:risolates from' 
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Results 
The""percentage resistance d.e;tected-in -G. jeiuni isolat~ in 
br-operS{n=5:5}was 4% m-cip,rofl~xacin, 93% intettacyclilie; . 
4_9% ,_in erythromycin;:- 31%'-in ,cettriaXOn¢" 55~-_'-1n 
'darithromy?i:q, -7% in ampicillin,_ 25%- in' naJldlxic:-acid -and 
0%, m,' 'gentarnycin. A -def'uiite :_'siUft -'towards mcreased 
resistance was ev,ident in'- cornish thicJcens 'Cn=17} which' 
showed 17% resistance to-:",ciproiloxa'cin, 100%'-- to 
tetracyc1irie; 44%t-o--~rythrO±ny~in, 50% to' ce:ftriaxone, 67% 
to ~larithromyCin, j 3% ,to ampicillin, 39% to' milidixic acid 
poultrYagainstantibiotics_comm(1ll1yusedintiuman~ei;'ap-y-.-
Methods... .. . . .•. 
Thermophilic Campyldbactet-,spp ;.v~e .-isolated fi::o~Ahe~ 
caeCUDl of broiler (5:7 weeks)andcotnish(38'42Cvle~koldl 
eltickens_ Isolates: -were'--sl1bjycte_d,_to"MIG deteriilmatiQns 
using the CLSI:ag~rdjlutionmetho,d __ __ 
South Afr J Epidemi,,1 Infect 2007; Vol 22 (2;3) 
FlDSSAAbstracls 
and 17% to' :gentamycin. MUlti,-resistaIlce was -:4etected' in 
1:8% of the isolates from brQiler'_c~~k;ens showingre~istaD.ce 
to 4 or more antIbiotics: In c(j:ritrast~_,4 i %~of-the i.~olat~ fr?_m-
cornish-chick~ns_?howedresistance to 5 orxpore antlbioti?s,-' . 
C01tchisio:n, _. . , 
Reservoirs of re'sistance genes in food animals -- have '-the, . 
. pOtential to spread to the human population, thereby . 
decreaSing.alreadY dwindling antibiotic treatment-optitms .. 
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Antibiotic resistance patterns of Campy/obacter jejuni, C 
coricisus and C upsaliensis isolated from paediatric 
pati_ents in Cape. Town .. South Africa, 1998-2011 
t jpda BeMet Laeeqa Basardien 1 Albert ,! ! astoylca 1 
1. University of the Western Cape, Bei{viffe, South Africa; 2, 
UniversitY of KwaZulu-Nafal, Durban, South Atrica 
Introduction:. From 1998 to 20.11, a 14-year period, 17,802 
paediatriC diarrhoetlc stools were submitted to the diagnostic 
microbiology laboratories at Red Cross Children'S Hospital 
and Groote Schuur Hospital in Ca,pe T own-, South Africa. 
2~946, I.so1ales of- Campyiobacter spp. were- identified. 'Antibi-
-otiC', susc¢ptihility studies- Were- done-by diose diffusion at 37'C 
with.erythromycin(15 pg), ceftriaxone{30~g), ciproftoxacin (1 
~g), and tetracycline (5 ~g). During 2010 and 
20'11, Campylobacfer' iso-late~ were collected from commer-
cial poultry farming- systems (free-range and industrialized) in 
KwaZulu-Nalal" S-6uth Africa. MtCs for tetracycline were 
determined using agar dilution. 
Result,S: _Since __ 1998, erythromyCin resistance for C jejuni 
(n=-1,232) increased from 3.4%- to 7.2%, Ciprofloxacin resis-
tance increased ftom 1.4% to 31.0%; ceftriaxone resistance 
-increased_ from 3.6%_ to 24.6oi; and tetracycline resistance 
increased fro'm 14.2% to 7~:O'%. C concisus isdlates (n;:;680) 
showed increasing resistance to ciprofloxacin 6.9% to 18-.0%.,; 
to errthromycin 4.8% to 27.3%; and to tetracycHne 4.3% to 
100%. -Ceftriaxone resistance remained stable at 2.0%. C 
upsafiensis isolates (n=702) showed increasing resistance to 
tetracycline 4.3% to 100%. Erythromycin resistance was 
oonstant at 9.0%, ciprofloxacin at -1.0% and no ceftriaxone 
resistance was noted. An increase Hi' antibiot-
l\c~~esistant Campy/obacter ...... '35 also._ noted for paediatric 
biood cultures, adult stools and chicken isolates, In 2005, and 
subsequ~nt!y, multiple antibiotic resistant isofates (I.e. c!-
profloxacin + erythromycin + ceftriaxone) of Campylobacter 
were (selated from paediatric stools and blood. Collec-
tive Campylobacter isolates from chicken (n::::161) showed 
98.0%, resistance to tetracycline. 
Conclusion: Observed increases in antibiotic resistance in 
clinical and chicken isolates of Campyfobacter are relevant fcr 
an understanding of transmission, and other parameters. 
Tetracycline usage in the poultry industry is possibiy contri-
buting to the increasing resistance observed in the clinical 
iso\ates. 
DOCTOR OF PHILOSOPHY: Bester LA (2013) 
CHAPTER THREE 
CONCLUSIONS, LIMITATIONS AND RECOMMENDATIONS 
3.1 Conclusion 
The following are the main conclusions of the study: 
• Campylobacter spp. were prevalent in all the farming systems, raoging from 47- 94 %, 
with the lowest rates of isolation in the broilers aod the highest in layer hens. 
• Campylobacter spp. were present in industrial poultry production systems in South 
Africa with concerning levels of resistaoce against first-line aotibiotics, such as 
tetracycline, ciprofloxacin aod erythromycin, which are used to treat 
campylobacterioses in humao health care. 
• Resistaoce was highest to tetracycline (industrial broilers 98.2% aod layers 100%), with 
the hlghest susceptibility noticed for ciprofloxacin (broilers 96.4% and layers 100%). In 
addition, multi-resistaoce was detected in isolates from the industrial broiler (23%) aod 
layer hens (43%). 
• There is a clear relationshlp between restricted aotibiotic usage aod the prevalence of 
Campylobacter aotibiotic-resistant strains in poultry production. Compared to the other 
groups, isolates from rural farming systems were significaotly less resistant thao isolates 
from commercial free-range and industrial broiler aod layer systems. 
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• Plasmids were harboured in 75% and above of the isolates tested, and originated 
from all the different farming systems. However, no correlation between the presence 
or absence of plasmids and the antibiogram profile could be concluded. 
• The PFGE genotyping of 42 Campylobacter isolates generated 39 SmaI types, and it 
was evident that substantial and substantive genetic diversity was observed between 
and within farming systems. 
• There were no correlations among parameters within and between farming systems 
attesting to the diversity and complexity of phenotypes and genotypes and indicating 
de novo evolution to antibiotic selection pressure. 
• MALDI-TOF mass spectrometry was shown to be superior to the biochemical tests 
for the identification of C. coli but equivalent to the biochemical tests for C. jejuni. 
The identification of Campylobacter species is challenging, given that current PCR 
methods are not standardised. However, although MALDI-TOF spectrometry 
technology has shown to have important advantages, in South Africa the apparatus is 
expensive to purchase and it is uncertain if it could be considered as a diagnostic tool 
in the near future. Thus, biochemical screening is still cheaper and the use of 
alternative advanced molecular techniques to confirru Campylobacter identifications 
at specie level considered a preferred method of diagnosis. 
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In addition, the study has shown a number of important aspects concerning antibiotic 
resistance via the food chain using Campylobacter as a case study: 
The prevalence of Campylobacter was widespread in all farming systems, irrespective of 
the presence or absence of antibiotics. In fact, the industrial farms could show less 
prevalence if the biosecurity were improved, the current risks being increased during 
'thinning', a process where the poultry stock is reduced for slaughtering and the 
biosecurity temporarily compromised (Allen et al., 2007). 
Antibiotic usage on an animal production farm has the ability to create antibiotic resistant 
strains of bacteria that can be reduced with the prudent use of antibiotic growth promoters 
and therapeutic antibiotics. However, this does not guarantee the absence of antibiotic 
resistant strains. Even chickens from the rural areas carried antibiotic resistant 
Campylobacter strains, therefore other sources of resistant genes with conjugative 
properties are likely to exist. 
Therapeutic treatments of poultry also pose a risk, as was found in the layer hens where 
resistant strains are often maintained and do not necessarily disappear when the antibiotic 
treatment is complete. These strains have the opportunity to accumulate during the longer 
lifespan of the food animal. 
Considering the high prevalence of Campylobacter in poultry, it is peculiar that larger 
numbers of human cases of campylobacterioses are not reported. This might indicate that 
not all infections originate from consuming infected poultry products. Flies, for example, 
have been reported to be an important source of infection and are probably also a source of 
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spread to humans, hence the difficulty of tracking the infections through epidemiology and 
genotyping studies (Raid et al., 2007). 
Caution must be taken when reporting on the source of clinical antibiotic resistant 
foodborne bacterial strains. A number of factors, not yet fully understood by scientists, 
may playa role including but not limited to host specify, natural bacteria evolution, the 
make-up of the commensal bacteria in humans/animals and the environment. 
Finally, it is evident that little data is published on the transfer of antibiotic resistance via 
the food chain in South Africa. The possibility that the agricultural sector and environment 
has many reservoirs of antibiotic resistant genes jeopardising the therapeutic treatments of 
clinically ill human patients needs further research. Not enough information is currently 
available to determine how antibiotic resistant Campylobacter and other foodborne 
bacteria impact on our health care system, and how it impacts on immune-compromised 
patients. 
3.2 Limitations 
This study focused on farming systems in the KwaZulu-Natal area. More farms and 
abattoirs from other geographical areas need to be included in an expanded study to 
ascertain the prevalence, antibiotic resistance, plasmid profile and strain typing country 
wide. 
Cost constraints precluded the inclusion of ali isolates in all tests. The use of representative 
samples may have under- and/or over-estimated results. 
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3.3 Recommendations 
It is recommended that: 
• Biochemical screening in tandem with advanced molecular techniques to confirm 
identifications at specie level is used for Campylobacter identification in view of the 
high cost ofMALDI-TOF equipment and protocols. 
• South Africa institutes a veterinary surveillance system to monitor antimicrobial use 
and susceptibility trends in selected zoonotic bacteria such as Salmonella spp. and 
Campylobacter spp. 
• Surveillance generates the evidence base for regulations or legislations on certain 
agricultural practices and related occupational health and safety 
• Communication between the medical and veterinary fraternities is strengthened in 
this regard. 
One has to be cautious to state that the majority of clinical antibiotic resistant foodborne 
bacterial strains were disseminated via the food chain. Host specify, natural bacteria 
evolution, the make-up of the commensal bacteria in a human/animal and the 
environmental all playa huge role; not fully understood by scientists currently. The study 
recommends the establishment of surveillance centres to collect data on not only 
Campylobacter, but other clinically important foodbome bacteria in South Africa. This 
should include geographical surveillance data on clinical isolates from humans (including 
antibiotic susceptibility data) as well as surveillance data on isolates from animal 
production farms for especially poultry and swine, processed meat and the environment 
including water and soil sources. 
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Finally, it is recommended that the consequences of the use of antimicrobial growth 
promoters in South Africa receive more attention. Veterinarians and food animal producers 
need to be trained with respect to prophylactic treatment and possible human health 
issues related to antibiotic resistant bacteria. There is little published data on the transfer of 
antibiotic resistance via the food chain in South Africa. The possibility of several diverse 
reservoirs of antibiotic resistant genes jeopardising the antibiotic treatment of humans is 
thus a research area that needs attention. 
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